var title_f33_3_33840="Lymphomatoid gran CT II";
var content_f33_3_33840=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F60848&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F60848&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 526px\">",
"   <div class=\"ttl\">",
"    48-year-old woman who presented with hypercalcemia and multiple pulmonary nodules",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 506px; height: 199px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADHAfoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5UoorWsdNiuLaORmk3NnhSPXHpQBk0V6n4J+DeveLmVtOs7hLXPM8xCIPxIr23Qv2U9BS1DeINd1N5+4s2jjVfxZDn9KAPj+ivs1/2X/Ag+7qniVj/wBfEA/9o1Gv7Lvg12wmpeIz/wBvEH/xmgD42or7Tj/ZV8FbR5mqeI93oLiD/wCM07/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmoX/AGVfBwzt1TxCw/6+IQf/AEVQB8YUV9kP+y74NRsNqXiMH/rvD/8AGqWP9mDwRk+ZqfiTHbbcQf8AxmgD42or7Ju/2VvCE1q39m65rsVxjKmeSGRR9VEan9a8r8Y/s6+IvDoee2VtUs1/jtmG4D3UjNAHhVFdLP4ejgdo5TPHKpIZJPlI/MVXOjwKcFpQfQkf4UAYVFbv9kQf35fzH+FH9kQf35fzH+FAGFRWy+m2yyBC02SM8YP9Kmt9EjubqO2t/PlnkOFjTkk/lQBgUV9J+Bf2ZbrWLRbrxBd3OmRtgrENpkI9SCOK75P2VvBKIBPrHiEv6ieBQfwMRoA+LqK+01/ZX8DPnbqviUj1+0Qf/GaQfsq+Cy5B1PxGFHf7TAc/+QaAPi2ivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtX/AIZU8D/9BXxJ/wCBEH/xmj/hlTwP/wBBXxJ/4EQf/GaAPiqivtJf2WfApJH9reJARyc3EA/9o0//AIZU8D/9BXxJ/wCBEH/xmgD4qor7F1H9lHw4ysdN1zV0b+EXBjcfiQgrzPxn+zrrmhxyTaes2owoMnysFj9BigDwaiumudBtrf8AcytcLdg/NEcArz3BGaZ/wj6bGJMwIAIGRz+lAHOUVc1S1WzuRGu77uTu+pqnQAV9ffs0fC7w9e+BNK8U61H9tubkzGOCX/Vx7JXTp3Py5r5Br70/ZjgLfA/w0xdFU/aep/6epaAPTxMIkSO2RYYkGFVVAAH07VGSTyTkn1NSyJGAFhZmbOCPWp7a32Ydx8/YZ6UAQQ27OVLAhTzmr6KEUKowBVfUL+0022a4v7iK3gXkvIwArhrj4kQXs3k+HoGuQTt89xhfqB1NAHdX17bWFu097PFBCvV5GAFcVqnxZ8KWEjILyW5cf88IiR+ZxXI33hzWPE2pTNdTS3BKlkEhwiD0ArjPEng24tZEVrWUHn5QvTj1oA7DWfjzBCSNM0eSRezzyhefoK5q7+OviPfuj0/T4k5ODk/h1rzu90q4gUC4iYKx7gis+eKQyZVQ6jhs9BzQB6za/HfXgga40qzkHXKkjP4V1vh/45aVdTLFrVnLYkj/AFi/Mua+eZBIAgTJYnacD174q21iUw08giwDtXqc/SgD6jX4q+ESFP8AaeA3/TNuK37PxXoN3BHNBq1mY3+6TKF/nXxvC9r5xQRzqn94AdcelWLGzm1K9S3061uJpmO0DH9P60AfZqatprkBNQs2J6ATKc/rVxWVvusD9DXzr4O+D+o3TpcarK9lGp3fe+avd7JYtPtIre33SeWoXe55NAGpRVNHnmPB2qe+KeLdiSJJWK/WgCzRTUXYgUEkD1p1AGJ4o8U6T4YtVn1i58lW+6ApYt+Vef3nx38NxswtbW/uAO+wL/M16ZrGj2GsWrW+o20c8Z/vDkfjXinjf4Ox2qyXehbio5Ken1/z2oA6HT/jr4ZuJAt1Be2oP8TIGA/Ku+8P+K9D8QrnSNSguGHVA2GH4Gvj7UdJe3uZIpYvJkQZxjgjviqERudOmS7s5pIWHKSRthh+IoA+6nVXGGAIqjPbmMbgcr/Kvn/wN8bdTsAlv4mge+tR/wAvCDEqj37N/OvdfDXijRvEtt5+jX0VwB95AcOn1U8igCSpo7mRCMncPQ1PcQEqPL7fw/4VURMyBGyueORQBzXjLwB4Z8ZQOupWaw3TDi4iAVgf6/jXzR8Svg7rXg8vPaA6hped29V5Qe9fXkiNG2GFSP8ALG0N1GJIXGCrcgigD86wvB5AI6g8U2vp/wCMfwTgvIpNY8JxBJOWktkHB9x+tfM11azWtw8FxGyTIcFCMGgDvvhP8K7z4gStO1w1tpcchieQLnLAAkZ+jCvqfwB8LfDPgpUk02xWS+A5upvmfPtnpXGfsjgr8ONSDAg/2tJwf+uMNe3UAFFA6etNcMcBSB6nvQAkYcZMjAk9gOlPpGYKpZiAoGSTwAK818ZfGDQdAle2tCdQu1yCIj8in3agD0uq93e2tmM3dzDCP+mjhf518+RfG3Wr5rxYba3jyhEQVfuHscmvM7671DV71rnULie5uZPnJdiR+HtQB9Uan8RvDFgsm7Uo5mTqsILHNcbc/HfRUlKQWF1IQep/wrw7Tzm0uVVcyAbgcVmxuZIxtG1mBHIyc0AfQtv8dtFZWM+n3ibTyVANdn4c+IHh3XlH2S/jjk4/dzHYefrXyTt2Ko3biByfen7TDIj7jkgEAHGBQB9t+fDt3ebHt9dwxT1YMoZSCD0Ir4taW5dVEd5dPDnlFc/yqxZ+Jdc0VhDYavfQMe284H4ZxQB9l0V8jQfEHxg82x/EF0o65Azn9K6bw7d/EbX5U8rVr+KFukrfKAP60AfSdFc74ZTUNP0xIdUvGvrnHMrcVqCed2+Tv2AoAvUVHGsg5eTd7ACpKAIrm4htYjLcSLHGOrMcCsK78a+HLTPn6xaKR1G/JrZ1Gxt9RtJLa7jEkL9RXkHi/wCCttceZPoFw8Lk7vKY5/KgDtm+JvhJXVTrEPzdDzitrTvE+h6lt+xapaSlvugSAE/ga+RvFPhLUdAvPs+oW+wlgEdBwfrXMXENzA29GaGSI5JDYxQB98EZGD0oAwMDpXyP4D+L/iLw4/kajIdSsQQNkx+YDoNrV9HeC/HOi+LrUNYXCrc4+e2kPzr/AI0AdVSEjIBIyegpaayh1G4e/wBKAOV8SfD7wt4ln87WNFt5bkj/AFoXa34kda868Rfs9aROXl8P6hcWUp6RzHzEr3DHrTZJNhxsdvdRmgD86/jP4Rv/AAX4uj03VBH5z2yzo0bZV0LuoI9PuniuCr3/APbUIb4p6WRn/kDRdRj/AJbz14BQAV94fsygv8EvDSqvzf6T+P8ApMtfB9ffv7LSKPgZ4acD5j9p5/7epaAPUoIRED3Y96x/GPijTvCekPf6nJgDhIgfmkPoKf4v8R2fhfRJ9Sv2+RBhEHV27AV8neLfEt74u1iXUNQP7sn9zF2RfTFAF/xP4v1TxhqzXGpSGO2BJitVPyIvbjua9v8AhJoFs+ixX80eXyVQfSvna12oke7kucA44B6da+qfhXIZPBVjuXaVBX6+9AHVoioMIqqPYYqOe2jnZTKqsBkYIzmpqKAOO8beGLG90OZILUCUKSu0cZxXz94j0aPSdJmF4TC8sgLqyYIGe1fV8iszIB90HJ/pXiXx80uF54Z9gOEz5ecZNAHiaXkcUBFqhRNww7DLEDpUWAeVkZyx5DZzUZQ+YGBwoHCjpXqnwi8FjWbw3Vyu61XB3nigDN8CfDi78Stvmd7eEYJbb2r33wj4L0nwzEPscIa4xzKw5/D0roLO1hs7dILaNY4l6KoqagBk0YlUKSQM54qI2qfwkgjoasUUAIowoHoMdKWiigAooooAKRlDKVYZBGCKWigDyH4oeDYv+Pu2jBUk8AdMjkV4MbN4rq5tJ2PlMCyk46j/AOtX2dqFpHfWkkEqghgQM9q+aviR4aewvHwuCvOSaAPMUUTP5fJTHyAfh39fap9Mub3RtRhutOupbe7Qghoztbv+f40yMvBqUQAUlsA7Rjr1p97b7NQmhkVvMU5Lg0Ae8+AfjVFcmOz8WRrbyE7VvYx8jf74/hNezxvDd26SROksLgMrKcgj1BFfDsZaSL94u056eteifCr4g3XhbVIrLUJnk0OdtrKxz5DH+Ieg9qAPpi5ik2jB3KOSe/4+tKpW5iwf9YoqeGVJokliYPG4DKw6EVUkBt7jdjK8kdqAGI0kDcggeh6GvIvjb8J7fxFZyaxokSx3yrudFH3v8+le1yPGIwXxtPqM1VsyxmYjAU8kAUAeS/sp209p4B1a3ulZJYtXlQq3bEMNezZGcdxzVLStNtNPF0bGNY1upjcOFGBvKgE/+Oir1ABTZZEijaSVlSNRlmY4AFOJwMnpXz38d/iI8jPoekS4gziaQcbz6fTNAGP8X/ind6xfzaNobtFpi5R5ozzKe/PpXkyJvJX5vNJ70JGZFLbhnPOf55pwjlRC65A9Qe1AGx4clW31RJJV2I2Y3A6c45xWtf2k9pBcpJGWO7Ckf3T9PpWNYkzqnlHMqcjgDd6g13CB9Y8Px4XbNFgO57igDjIrWUtmN1U4zgtggVantLqO0iMcZMbD5mqhdRtLPIpUnBIO3P0qa7u5rizht2dgsKlQBwBz1oAh2LGwE+1i44UHrUklwJGG+FNoGAF4xVNiBIihVyPXjA9qntoXuZNkI3NnHHrQBc068itrtJGjYIuTtDZye1dJ4K8HX/im4kliidBnczMOnNdR8N/ho2oTrc6khEI53dK980zTrTTLVbexgSGJRjCjrQBwnhf4XabprJPfgTzgdO1d0LCKNAluqxIowFA4q5RQBUjsxg+Y3PbbVpVCgBRgClooAKKKKACiiigDI8TaDZ69psttdwRuWGFZhyK+S/if4WuPD+p5jRisZ2nAyOvTHpX2TISMEHABy30xXDfFPw1DrekNPgFkXBAHJGKAPkaa3SaOO7t95iP3l7K2KXTriaxuTeadcSQyIdwkRtu0jvU+s2d1o881pEh8h33HJ64puk2st79phCqWIJVSQMgUAe1fDr45skken+M1Oz7q6gi8f8DH9RXvtpc299bRXNpNHPA4DJJG2QfoRXwzbWqFyZZFCL1xz09a6nwH491jwddtLZSefprP+9tZD8pGeo/un3FAH2JRWD4N8Vab4t0hL7S5c8Ykhb78TejD+tb1AHxV+2owb4qaXg5xo0QP/f8AnrwCvfv200C/FPTMd9HiP/keevAaACvv/wDZcOPgT4ZJ6f6V/wClUtfAFfYPgfxKfDn7KmgeQ+26vDdW8fOCAbmbcR+H86AM34s+LZPF3il7WxlUabYkxxkniRu5rjbazfzmt440lJ67T93nqKz7UmR1GRgr2HVv6f8A163NGsp2vIhF5bM/BBPIoA6bwroT3dkYHtZJH8zIYDjBFe/+AoRY6NHYjOYsn1x7VkfDHQpbTSYprpCjZOB/eFd4qqpJVQCeSQOtAC1kPqzDxCNOSMFQgZ3J6E+n6Vr1VNhbG/F75QFyF27x1IoAXU7r7Dp9xc7S/lIXwO+K+ZfGvi+8124mju4w0YBKllxjnpX0/cqHgkVkLgqQVHevnb4l+GpLG6IMXkpJ84A7j60AcB4dsf7U1VINnLEEbeAOa+tPCekQ6LoVrawqFIQFj6nFeBfB3ShJ4gjEyMx8wdP7or6VoAKKKKACiiigAooooAKKKKACiiigAri/iNpMN3ZecY90hG0nFdpUN5bx3Vu8MoyjCgD478T2ItLwhEKr+VZMshkkaRzlj1Neh/EyGC2uZogrbgxwSOK85hOyZIwpbGACRwaAL0ESy+HxdOq+b5uwFRjiqc0RVVD7fm5wea6nUiVsbez0u1dgvzP8u7k9qwL2CZdrywPGxznK/lQB7X8B/G3m248OapLlowfsrueq/wBw5/SvaHG5XjHBxgc18TWlxNZ3MVzbOY5o2DI47EV9SfCvxnH4p0dY5yBfwKBIM9R0zQB06s20xEZGencfSpLRjG+HBAfgcd6sXMQcBsHI9O4qsoeYgKSQp+8eozQBZtk2B19GqakUctxjJ/PiuS+K3iI+GPA+o38bbbgp5UJB53txn+dAHn/xX+MEOm3d1oWgFZLtAUmuAeEPcD1NeFTkalK91NKXlJyxJwW9axBvdy84LyOd7yE5JbNXoU2h3BBx91v/AK1AE0losjnygy5PTrVTbKgYbWAPB44NXlBmKmJxv9N3H41orCII91wp+boCvp70AReHf+PmJXBwCQ3HI7/4V634b0+KMzbcsu0sVUfrXK6NoDX4+36emVALkAdD/ntXa+Hrl7fU4rhcJ5UYXysc8+1AHOaLpFqNS157lT5dum5AQMDNebXVyTNKBwCC/A7dq9R8fXFzBd3MdkPLN9jcoPQjqK8vhRIpZC3ysQQcdzQBXlSEyQyxO25wCwbAxx2r1X4V+EXv7yOaYMAx5yK4DQrWDUtRghQfvEPzknGeeMV9V/D/AE6Ox0OMqoDN3HpQB0NnbR2dtHBAoWNBgCpqKKACiiigAooooAKKKKACiiigBkyGSJlBwTSNErwGKT5lK7TxUlFAHzV8Z/Cy2108iR7gvIGOteQ+Gk8rXoWk3Qxbtjf1r64+Keli70tpdgYgYOfSvlzUbMWuqyhQu05OB2oAhvYDHf3KQ7DETwSPvCoYYnEJjmGASDirG1ipODt/vAVYt7cnQBcO5Mu8hAf60AXvBnim98IeIYtQsd7QMR9ohwQrr3/Gvr7Q9Utda0q21CxkD286B1I/lXxPcQyGIKGAYnkHjivXP2fPGD6bqDeG9Sk/0a5O+2YnhX7r+NAHmv7a3/JU9K/7AsX/AKPnr5/r6A/bW/5KnpX/AGBYv/R89fP9ABXuOjat9r+Gvg/S8Zjs4bliOo3PdSkn8sV4dXp3hNHPhixeMtuAcYB7b2NAHRxqIwAnAHSut8JxB9Ztd/A353AYANcZE4jAWRjvbnB966nQbh7aSN4vm24IPagD6x0NlOmwqrAlRg4/Or9cr8PJvtOjCc43tjPqOK6JoZI7SRIHPmHJUtzigCxRUVoJhbRi6ZWmx8xUYGaloAK8/wDGU39qXnkiBWih+7IBuLev0r0AZxz1rlPF9hGiQvAAjOx3ejUAcj4PS3sPFMMKxhWPRjxivWa8P1m6l0u9tbsrhY3AP0969l0m8XUNOgukIIkXPHrQBbooooAKKKKACiiigAopkjOCojQH1JNOGcDIwfSgBaKKKACiio7iUQwtI3RRmgDxf4p6Gst5Njdtbrx/KvKIPDs1xdLbxY8yVgiA88k19Q6/4fj1SJpVJ8xlzg+tch4S8LSWnioS3Ef7tAW+bsfagDpPBXhC20XS4RdRJLeFBvZhnmr+u+F9N1e1eK4toySS2QADW8DnPBFZ+p6nFZQO5dcKMk5oA+Y/iL4fh0a8aCzBKq5J5yTWV4H8SSeFfEtneEsIt4WWPONynr+la/xO1lr/AFuZ4E2RNxurh5FJIMgJYjIJ64+tAH2/BKk8McsZ3RyKGU+oIyKq3UflMGjyA3p2rlfg3q/9r+AtPLtma2Bt39fl6fpiu1lUvGQDg9j70ARWbFoiWJJz3NeA/tN64J7zTdDhbcIv38oH94/dFe53N4mmaTd3c+AkAZmyfQV8aeLtUm8QeIL3UpWU+a52sTjjsKAMm2hSd1QthiemOtWLi3udNnyoJD5XCkEY96rmWRDjaFJGM4wfrVnyptqTxq7bgCwA60AN0/Yd2QwIXqDwT2zXVeGbiEOqn9/g52k/Kfb/AD/9auQc/vpGJkT5cjsa0/Dn7m2eaYK5U8kHp9aAPpLw3aQy+GpL21t2h2Kd0ac5YDsKwLKVtQ1nfFHiPoQAMgfhWd4F+IOm24i0+4E5Zzk5Pyg+uPT/AArtfsEOkTy6to8YaGcEEhsqG9PzoA5v4geEJRp/9omOQvEpyyE8D1rwm7tXhnLSK28Zxk/er7L0KSPUdCjWdFbK7JUPIrwnxz4btotYu7OEK8YJKbhgrn+dAHEfDO3RtUDzMMk5BPWvrXQwo0q22qFG3oK+XPD1lJomqmKdOScrk4ytfRPhnVQ2ixbVUsrKg+bjBwPzoA6YOpcoGG4DJFKjK4ypBHTIqvJY20lz57xK0uMFjnkfSrCjaAAAFAwAB0oAWiiigAooooAKKKDwKACiiigAooooAoa9Es2k3CuoYBc818teP7XyL0NtXG7BK19WagVFpIHOAeK8G+IejJO0pUg7udwx1xQB5PpiySXqImAMjO7pit7WriCNYrXT41CL9/A+XPf6etVLLSbmOWRWhZieFK/56V1uh+E3vLc/alEL9A7cfp/WgDz692v5UvlhWYVBbtcpcJNZrIZ4ZA6lOcEfyruvEmgWGmNG010GK5G2PqPesK+1dorIW2mRx21sy4YqQXf6n/CgDi/2k9e/4STxR4ev2ZWmOiRRy47OJp815HXV/Ef/AJDkP/Xuv/oTVylABXqfg0D/AIRS0bzPLK7yOM5+dq8sr1bwRj/hGbLcMr8+R6/O1AGyzBtgV8bsEcdRWnplw8SsANwGOKzHitoYTM+7cGCogP45qSGQowYZHcg+npQB9BfCzxjaJatbXIMRAAOW44/ma9didZI0dDlWAYfQ18f2uqJFJtjJQrgqUNeueG/iRLZQ21vdlbksnAB+b2oA9mqKRWEySCXagBDKeh9K4HTfiPb3biCRFinZNy7+M+tVPG/jKSwEccb5WZM7Tjn2oA9JNzCJ0gMqCZxuVC3LD1HrXOeMb6CC1huH/wBXFKUkPp/nmvGrHXLi91GO8S7MdzEd0Ik6D2GTXZnV28SaZf6fc7INVK+YqsMLLgdAemaAK/iO3TVop7W2BfzUDQ+vPQ13Hw1ja18L21lcyh7yDIlHvn/9VeT2PilYYoDMuya0IhlyOQvr+FddpuqeVew3lu6nnovRh3BH4UAeqZ5x3oqG1niuoEnhYMjDg1NQAUUUUAFFFFABRRRQAUUUUAFc5431L7Bpq46sckdyBXQTSpDE0khwijJNeK/FTxHuJJYeXysYznd7D3oA9H8L+IrfXLNRb3SRzwnbIhwSRTvEXiSDTFkWMgzIvLkZ/Cvn7wdqN1aai7xgh3Ybt3U98CtvVdVvdVmKzJJEufLAIwW96APVdO8VQalZxPJKFLnjYPv/AJfhV/VtAk1ZEDTKIm+bPXj0qr4M0m0XQLWGSw/eQqMlv4s9668AKAFAAHAA7UAeN+MPh4sh2wFkiRd7ysMqMdTXh2rQpBfSRozPtJGSMZ9K+0LqJJreVJVBRlw3HUV81/F/SbXTdVWSELtlJKjnigDpv2bdTIl1bTHY4IWdAfXof6V7pXy58EL1rP4g2aBvlnVoj78cfyr6joA8v/aE1M6d4DkhjcrJezLH1xlQOf6V8twE7uFU7fmye1e5/tP3cjX+i2SMQBG0uM4GSSB/KvHLOGFZFluYzuXB2DufWgCSIG1j866cvGP9XG38VRR6peeaxRwkYBOwKMKPYVZlmSdszwKxHTnoKqXRsrcSSW8JaYgqFc5xkUASXeszT2ixukLMVIJ289e9c8t7cRM6ksEPDKOhqYPMy+YluwCtkgjgimvJIsE7TxrHHL8wyMc+1AE1pqZgt5NjMJRJlTnBCn0r3P4VeKUl04aFqJYpcLvBLdz0x/hXz+gE9q5yoeHAbHGfeuk0S7MF9Z3EcjLIEwoH6UAfSGheI4/Dd/OupSObCV9m/BOxu2ap/EdLY6nbapZzKYJsZlX7oPHWuR1jVgLWOGeFZRdRhpQP4T7f571RiuG/sybSpnMlncJlAx+6w6EGgDc8Q2S3+kR3UEeZoBuGzqRj9a7PwBpmq3FjYTOEjsXYSF2PzFR0AHrmvM/A/iNbIf2bqSnfCcLngmvXvC2rfZrW6+1yOY5WAhTsn0/OgDtEmiuEBhlVvQqc81Kudo3Yz3xWbFpyeUhiCbSMjjGPxrRQFUAZtxHegB1FFFABRRRQAUUUUAFFFFABRRRQBkeKLhYNMYNyWOAM4rya61RWnNs0KShiGO7qPxrtfHeo4Yopyq9MYNeMavfSPfeVAFMzHb83RR60AerG58K2OmjdBEt+BkiM7zn1z0FcprN4Lll/stJSvG6Rhx9BWX4asZLlpjMkn2UDaWwRk9yT6V2Fl4gtBZjTbS1j+QYMpGSPYUAeY+LLaW7uo2MZK7MMewIrkLmylhBZsbRnGM9M19EWvhb+143/AIQBkr715j4s8OppniB7YlgCM4NAHzl8REVNbh2jrbqTz/tNXLV3vxmtUtPFUEcZUj7IpOPXe9cFQAV634GWM+FLFt+xxv8Ax+dsV5JXrXgr/kVtOyMgByf+/rUAa17FDL86FllPBLAYJpiYWOMTFvMDYB7H/PvUtSRWzoQluCynkH/D0oAr7SEMiRsz9GyenPr6VZUuuoZUNHuwc56H6Vr2Wk6jPG3lhyeOgzxWrJ4XujMCkROUG5vf/PegDIl1KYIywoVZBneTyMHgj9a9Is2t/FXg+KSZ1F1b9HJ+YEdc+1cPPod6Jgqxs5U4GOT9P8+lbKXtnoVitrDG0l2VBcKxC5oA1/A3ga91qR1mjlt7VG4uPX/dr1PUPANm+nRx2c0sd3AN0c2fmLD1PpWr4BeWTwlp7zxLE5TJVenWt6UssZKDLDoKAPmzVLCTS9dlXWoCRLkOCMbvxro9FSztNP8AJtrgyxnjPBIHatf4mx296rpKrmRRwR3rxtJrrTL1USOZgSRtGRmgD3jwLrnkay2myuTHPyhJ6MO3416PXz74Q1Q2Gsw3uqQssyD93BnG3PQsa9x0fWLTVYFe3kXeesZYbhQBo0UUUAFFFFABRRRQAZ5x3qG6uYrWMyTsFT1JrE8T+JrbQgBOo8wj5STx0/8ArV414v8AiHLdzuQ7eXjGwCgDs/iB41jFq9vbOqqDg5POa8mmlmna3mulIUszqZBnH0/xrAutU+13qz3AkOeik8fWpdQ1y71CWJWkKpbL+6x0XHXPtQB6x4Si0jS7GTUr6VROgJDzN0XB6CuQv/FVtc6uJNOZVjVgxLqeea4W6v7u75mldlUYx2FV0Vthbywy+uen5UAfXngnXbXWdLR7eRWYcNtOeQOa6OvkbwR4hm0C/guYZJEUON0IP3x3PtXuA+K+mbI2dQNw9ehoA9IJwCW4A5r53+N17b3mqJY20CCaH5t4+8wrr/EnxVtLRYns2jcSr8wQhj/+uvFPEeoS6prMl7FKZNxz15H1oAs/DOVoPH2iN0b7Sq4+vFfXlfI3w+P2r4h6KwBBe6U49DX1zQB87/tJgN4s0vcAdtkCPb941eSMhBV9vXjJPavZ/wBpC1dtZ0y5CkoLYoT/AMDP+NeIzXSlsNucDHzZz70AWB17c9z2p1xBDsRo1V5VPzOegOO3rTasTLiHHyBl6qMAtxQBi3q3TRoxnbejHA3YGO3FUd0lyMvI+NoU7hnP0q7cEmUswK55APpWxZeHrm50uG9bCQ8hj/hQBiaXD+9MCYcTELtYYx9fwrrtN0CGx1KK6vp1NtAQ7KD8xPoKlsotIsLF5lKSXCtjJXJAPesy3lgebEE55Ygqw4PvQB6FBDaapJ5toGeEcgH/AD7Velgh8tY5IVZ4zlAQAFz9K9B+Ffhi0j8J200oDmfLkbenbrVbx94OSy0+W/0xmCL/AK2JueDxkUAeU39lBe3Mdww8u5XGWUcEds10eh3t4kC2l0w2KP3bqeo9K4vUrpkkkwjMU4zt4rJGsXT3Yc3EiqPujsP/AK1AH1N4F1Y39g1vKf30PTPda6evm3wr43n0vULeaY7mDBHAHDDNfR8EizQxypna6hhkYOCM0APooooAKKKKACiiigAooooAKr31ytrbPIxAIHA9TU0jBEZmOABk151448TJJ/otueenDUAc14v1MsJpk5ZRjIPNeU/2mDqG5k82SNiQSeD9ateJdclMk0EZYFuCT6VzMN1um3MPukgkDGaAPQn8f6h/ZyWUEcaqpHmdRnjpUGh61IupJLPDEkOD0GMcfrXBw72mYBm2kjleuPetzy7maxk8lkwOMFwG+goA+lPDfiXSG0eO4R0V/Ly5B6nvXnXinWrfxDqz3EUQxH+7zjrjvXk8Y1GxsZM+YkJI+Xdx+lMtb24iJuLVmaLAJCtwCKAOF+P8Qi8a24GCDZIcjv8AvJK80ruPi7qJ1PxJbXDAA/ZFXj2d64egAr13wOrN4RsAwOwCUgj13t1ryKvYfAY2+EbCTLkASfKDwf3jUAbunwJPPjnHHB/HNemeBvB6ahcw7yigHO09T9K8/wBP1PbOmYEPqQO1etfDS+XUJmS1MkMiDlmXKg9hQB6GPCEMcSxQusSjAyAOeDUY8MtbzQMQkiMdsmevtXUQmZ7aPzlC3BB6DgHnmq9hDdrFKb+Qu7AghDx+A7UAUn8NaXFZTo0aoWBzKeCv09q+fvFi2dnrDRR7ZAj8NjrzX0N4ktmvPDtxGN8R2ZwDzx2r5p1q1ja9dfOLyL8rD+6aAPpLwQ7SeGbJiAF2/Jjpj/Oa0tWv4tNsZbmbcQgJCqMkmsb4fXQn8L2MYRlMUYUk9DWxez2LwtFdTw7H+UhnHNAHzF4g8UeL9e8UT2Gj2486WQGOMLxszz1/Wuw8U6f5MMBQojwxATzR4+d8fMc+lehSafpOmtcTaVGjlk8t3HPl59+1eP8AxT8TJcXY0nSpF8hceY6Hqf7v0oA5K81q6ur0GNy+048w8nFW7XxDqMEyvaySxPH0ccYrK050s7pmlRZo4znjoSPX86lubyG6EZjEsUhbJjXhCPWgD6Q+E/i6bxRosgvlUX1qwRyD98Y4au5rwb4Ganbadrk9ncMI5LyP5PQkHPWveaACiiigAoorE8U6wNCtUvZmC2ynaxPTNAEXjTwtZ+KtN+zXTPFKvMcydVP9RXg+s/CvUdN1FzfXlvFpoOftUkgUY+hr3LTvG+h39hNdw3WEhH7xSDkf41h+PH0PxHo8AvppBptwpVblF3Lz1BHagDxeTwJPPdRxabMLxWHyPHypX+9mr1x8Pp9Jty2ovsf7pA7/AP1q978EeGdO8MaHbWemnzkVeJ2wWf8A+tXBfHueOGCxRZHWWUncEPYdM0AeQT6aikragP0BKjg00aeLa8KTIAjAbW2YyOvWmWd35cbMrzbxjIfjcfWtBL6OeOKO8YO4IK4GdtAG1HpOmyQq6bZD6AcVbi8LWVwCFdVOOufzrS0WHGnqy+W4YN06ba0bKwW5v7VYJF2heR94e9AHHX3ghBtMRL4Aww6AVg6r4a+yqcHDHvn+le/eIm01La3it9gdY9xZc9q8x8R3e5MTRqGbgBRknHegDN+Duiu/xA09mOUhDSn8B/iRX03Xi/wMtnl1q+uWTEcMIjVs9SxzXtFAHnPxs02K98PpJIcMmcH8q+W5omt7t4kXcCMkZA79q+s/i3G0nhr5SBhiPrkV8wXkCC5mt5kIDHKnuDnvQBTjBd1HTOB9Kr3LPueKMEMv3j6fSur0/QCTDKFZkyMqRjFWftVhp3miO3R7vdkbuOc0AcXDYX8zh/IfCgEFgRxWvNf3kNstoryRpHglcdCf8ird3rlwsMj3Mu6YjAUDCqPwrDivnlWQzoPn5L9OaAIGgnV2LuC+eQehqSCwnkuIfssTOXcRhV5+Y8VKLqBCqzgtxkMCeBWx4O1hIPEVtJGqlFmXKnGAfWgD6z8M2EmleG7Cz2hpYoVDAnHOOa4X4jeNdW0awnhOlRAMp5kJII+lda/i/T4tPa5lLjYm4g4FefW3xE8OeM5nW8sJGELFEjLDLD1/SgDy2LxBq1/olxPoWlwXl6r7pYGj3Fo/9kV1Mvw8n1Sy07UpQLIzRB57fb88Z9Mf5610kkNv4U1W+vtMsVggvo18qVlxsUdgfzrG8QfFG3s7M2tihub3HzMvKigCKz0fTNCgmeFWmuUXMbyngHPpXfeBfFtzJiLUpvNjPRjxs/8ArV4JJ4g1DU7ndcEKWz8sY4FX9I1i7s4jlJdm7kHgjHqKAPrSN1kQOjBlYZBHenV4D4X+Kz6XdxwagGe1ZucDoD3r3exu4b60iubVw8Mq7lYdxQBPRRRQAUUUUAFQ3VzDaRGSdwiDuamrlfFfh+fUmaSHUDboR8wcZx9KAOc8a+NkSKSGF1RQSM59q8f1bxE5uBLCpdh/COevqaluvEOg33jGbw9NaX8k0coj81Wwx5/u/hXseifCvw/axm4EdzJNINy+ew+X8KAPnOS18wvNIJA7fMI8cge9V5/IUlTsVkHEUZBPbqelafi4mTXbqC2uSYUdkZUOFGD3rDd4LWKQQbZHzgZ6L9aAG3Usojy37iE9FTq341WltZoU8wOcNz6E1DcSzyzkuhdhxj+774q7FK09qVJBJUr83Y0AS6BqFwk8sDSl4pF+63O2oTNzKYRsUZABPU85FaGk6aT5k6RMJQAFQ9/WqF9bFZPMkiYuzdAf5+lAHnHxAkEmsQEDH+jrn67mrmK6Tx4pTWI1OMiEdP8AeauboAK998J6a1t8NfC96F+W7iuDn3W5lX+leBV9i/D3Qxq37L/hudQfNs2uZcgc7PtUu4fyP4UAcFbWMpn85f8AVN3PrXX+FNXvNHm8xJB5SfwhevpVPRLKW7uorO2jZw5wVz+tey6J8MtNhWC4vd5uVwSqn5fofWgDsPD+oR3mlW8jSAybBuzwc1yHjHUr7S9ftrgLI1oXBGGwB71q6z4dgg0mdQlxcuWHlhSQV+uO1eWeJ3v9JSIajcyuOsUDtk/TmgD0nxb4qUaW8VkU3yJy5bIAr5+1LV5jNM8CRklvmdVySM9ql1bXZ7sFcGNF6KOMDvmn2zRPYuHRcnkuRwPWgDofBviy/WyayN7IkS885H0rlvFOuTw6tFLZ3DsY+W6kHPtWZqji1vRJas2yUZOe9UtOt5r3UI0TLsW3HtgDrQB7Zofi2EeEGiuvlvrldrgdx6j8K8s8UaQlrfE27ZST5gT0/wD10/xFcMl9bG1YFI8Dg4+buKlnkfVLyNRkO6jK+pA7e9AGZp9vE0JefciM2HG08VoyaZApieGcSW5O1Tt+ZfrXZ6X4Jnl09Z7mDZGSflLc4/x6VRn8KSyXy2NiJWDPtUHPU0Aa/wAONI/tDX0+ww+ZFbFS8zdFx6e9e/VieD9At/DmiQ2Nuq7wN0rgcu3c1t0AIQcnDHtS0UUAFZ3iHS49Z0W7sJsbZkKgkdD2NaNBzg7cZ7ZoA8dT4dy6VBJbRXBL3GBz90VTstL1FdJ1PwvIgO11nhfHJ5+YD+deheJbue6Fnb2bMJZWOVC8jHX9K6GO0toWS5aNFlSPb5hGDj3oA82nnv8AwlpliEunEkiFpIpDlcZwMVzHi1RrFm0rB1lIO7fyA/sa6v42XtlJ4bXyZEe53gDaeg+teUaFqd66vCkxbK7SrDP0NAHPFHtJj9thYxZwGTkVq6Dcae8jJIrnzDtXC5INV9Qe7nkNuY9sak7lxjPqaXwy5spxK6Rl2kBQduPagD3Ky8GWK+Hg7X7xq6c9lz6VP4d0iLRQbgqGt/LwzscKM98etXNI1fT9Y0BILglAOF/3hnv+NPn0430EVmCRbq2+Yg8P6ZoAytee2jtp721QMSm2JCO/rXiniHU7kX5F+oU4yiqOF9uK9h8W6ethZxxROURRld3X8PwryPR9FuvE/jK3sUX5WlzI+M7EByTQB7n8HNHOmeD4ZplxcXjGZiRztP3Qa7qmQRJBBHFEoWNFCqB2Ap9AHPePLX7V4dmQAZBBGa+Wtdt3t9eZXB74Pr1r651qIzaVdRr1ZDXy94wgMmpbl3eZGxyMdjQBu2rRTaPHErIso/M1qaN4LiSUalr0by28SlgqdSSOP5VneD4xJYNNcSIiLjGRk59a7XUvGFvZeHWhKNI8g45546UAfPniqSJdYkxEdokJEY4AHbPrWVdXEuSs6FQ2CqgYHPcV0OuwySPdS3EIVpzuBPVPpXN3dvKYYkLtLKv3ZMc49PpQBFBKHmKyg7U4/Cren/6NdtcQp/qmBLg9BzVCKNln3zYznBCjtWxLo93clP7LjaSJ8Fl78c0AdNrnjSabQ1soiMOu0t3/ADrD8H2U1xrFvLA5URNuZhxjFVYtHv3UoYSiBud+OD/kV0ttJZeGNHG1mlu7jKuQOB70AdX488cp4nsk0ZlEQgGzcvHzAdfpxXlaxMgGG3fNu5HPTmmBZLbU9zZZHzgY+8D3zVqCMiP5lDovBz6dqACKWTIkyyv1681q/wBrXiwBLgCTIwrN94VPp+mtM6TWasyEfMrjOP8AGptXitLvVniZjA6oDwPl/wDrUAcvcySy8/OWz85z81fTn7Pmoz3/AIAjW4yfImaNGJ6jrXieg+CNS16eKLT4y0bsMzAcAZ/Svp/whoFt4Z8P2ul2fMcI+Zj1Zj1NAGzRRRQAUyaRYYXlkOERSzH2FPqO5ANvKHxtKEHPpigDK8OeJNP1+0knspCoiYq6SYDL7/Ssu68c+Hk8QW2kXVwFnl5idx8hb0zXgtlqlxaX969kxxvcGKMnJUE/nXH+ML24u7hZYQ4njYFWHXg9aAParHxFo48f3Lrpdk95zGZzH8+R0rpX+KNlJa3EawtDeR5XEhwM+1YHhnweb+CDXZYitzcWfnHaOsm3+ea8Dv8AWbyLU7y1vHZv3rKwZcc59fWgDoNb077RdT3dqULSMXK7h8xPesIxy2scuIV3PwwJGfwqWDVpkhjWJEdR0J6jjoa1LNBr+1IgIpYh0Kj/ADigDnipWORVCtLIOSe30rqfB2hRyx5uzjefmRhjjHY1Wt4NN0+R3u5TdyqTtReADWxZeL7maaG0tbSHaGB2hQCM8daAN/XNPg06JXWURQImFwvLV5nql3G7s6AqCSVDdSfwr1/4oRRSWME9s/70RKGjA4BxgmvGdQSN2MhfAxyAM4J/nQB5p48dpNXhLnJ8gf8AoTVzVdJ47Xbqtuf71uD/AOPsP6VzdABX37+zDGkvwE8ORyKGjcXSsp6EG5myK+Aq+/8A9lz/AJIT4Z/7ev8A0qloAseFvDkekeMrmGVPljbdAMcFD0P4dK9NqnfwAvFdKuZIMngcle4qxBMk8SyRNuRhkGgCSvNPjFokV7Bb3RaNJFyBu6kjpXpdebfFvU4hbJb70ZIgXkGeh6AfWgDw3UYpZZywRY3JHmL7juKm02RXga3VDJgncp4I+tWLKC71G/LqNyuhCktgY/GtGWSDRNOJjCy3b/K8gHSgDE1XS4FhEl1ex25Az5WMkjsBVGxuraFmjsVYHyyTI45b2qpqiGSdpZZeNuVyTlvTH50zSJPKmZnAMTDac0AN06VRJILn545jk7uzDFeqfDeysbnVIZbiNN4G1SCBx615XeW0sEssKRs0f3gdpPHrXQeCdWayvYdoyqH5gx4H4mgD6dGlQtCJCGQoMrg54xWZoWnRtrslzhWWJflOO56cfSuZb4hWaG1s4vMXCYYAZBPtXX+Cg8tlPdyDHnyZUegH/wCugDoqKKKACiiigDm/FviW38OyWYm3SS3T+XHGDgD1Y1v2kgmt45QSQ4zyK8k/aDguYrbStQgyY4nKMAMkE96r+FfiJnR7VGkKso2gMck47mgD2FY4ImMqIoJz8yjNY3iXV1s2FrImEmXBc/0rItfGsa2Ut7doFjwMYYYJ9RXnPjrxrNqniG1XTyI7ZcYZ+Q2aAOe8YXMtxqMttOx8i2PyEDG4ep9a1Phr4ebUNSNxEGCxDG4dDmpNfsG1JYTGEMvG8Afe9DXpPwytJbOzkiu/Lj2H5VGOfc0AW7PwZYwObu7jR2UElCOCO+a5zxJ4Ei1aZLjSYVtoCQQVGAF78ev+FekarLCtrJHPMsYkXaM+tZun2p0/QY7e0n8yRmJLtz1PNAHnuheC9U+1FrWVoLOAERh/4z649TXceEtPu7WBob3cHbmQAYAPbmukjlVYVZ/l4796lxznvQBzni/SFvbMyIqho0IyfSs34b+F4dGtZb1lzc3Pcj7q5/rXaMoZSrDIIwRQAFACgADgAdqAFooooAQ4JKnnjkV85/FXQv7P8QybCQjncv0NfQkj7LxPQjFcl8UtEXUtF+0xxhpYOT6laAPFEuVstPEMTfOeR6VnT6g0dsXBG4nIJ6AVFPKsW9eCUOPQms243uSJgwyOh44NAGfPM0/nPJKzHIwCevNZcccjXIdFZwQWGB7dK0njSFkEh3Z5YAUPdzGIxxv5SeiACgBmn6VFFMs2tTrDAfmCdWb2wKtarrktwhTTXMMUQCqsY25+tY9/vYIxJbb1J5qe0EeCWADMucL09qAKV7d3csxdriUM33hk8HHB/OtzV0NxYafcM0ZULhiBjp6iqDxRSOZJmIcYAz/HV/Tj9peSym2LA6/J2waAKAmUJsyWK8qF5GK6TwmbFTO+ooZFjUsqA9T9K5q7sjauEiz5qnlj3HtV7TrgJMsYUkSfIeMcn39KAOiTWDa2csUNvs3ElTjJwah0zw5rHiCZHsbeVnkO3PqPWqnmNYXa296pDxvkE9CCa+sfC1pBaaHZi3CYaMNuUDnIzQBU8C+Hl8N6BBZnDXGN0rjux7V0NFFABRRRQAV5T8b/AB43h/TzpWnc310pDt/cQ8YHua9VYhQSegr5D+J+oHU/GOpTyYkKuVUEdhQBmeCbjUYvElncQDCrKN+8YUjPINe1ePfB2hWszazGwWCYgyRA5UZ6gelfPlhctEqJE0hlLfKqdjW3rXiXUJrWG1lmmyDhg7fL+IoA+qV1i3TwcbnTHhQxW37tAcgYHAHrXyV4pkXUNSkub0bbvcS5CY5J71teHvF9/p89vZTy74HIVkXpjPatn4g6LBdxW9zabo7w5VkJHzD6UAecWY23CkbjETgnGMiux0VBbaouou3+jRRndtHD1mW3h++W38yWAeUGwq7hk+9dDHd2kG2zmjcRBQGA4ANAGHf26TXslxbRFoH+ZVHc/wCFb/hTQhaypeXgxOMui9hxxn3qxdaUumxx3Qd5Ld1Doq89al0/UN6jz1YN1jX25oA1fECyXEAhUB12ZO09/SvPNR0l5ZLeJo3THMmRjA9K6GXWhbaitxeFFTacRqOSfpRpt5P4k1SGOOPcXYKBt5BzwPyoA8h+O2nx6d4g0SOJAqPpUb/X99MM/pXmte6/tfWa6f8AEDQbSMALDoUC8evnT5/WvCqACvv/APZc/wCSE+Gf+3r/ANKpa+AK+/8A9lz/AJIT4Z/7ev8A0qloA9TR1fIB5Bwa4/XdRvPDF5vjiEmmzHI4OI29PxrrZEKsZI+vcev/ANemXNvBqFo0U6B4nHINAHC678Q4rayb7IgM5HUg4U149rWpXOtXnmbzvZsvk8GvR/Fng9rZuCTCWO1x3HofeuGfTfJd44ky/QjncPpQBmvG8ixpHJtjUcMuOvc0xNNaaD967OT129QfWtM2cMCRxXErBn4245H1PpTLRH/tid2IeBRsA5wR9e9AGLPopuGjExIRBjd9O1NltTHEiyRgr0z6V6D/AGONRMX2RQ0+NwjHVh6/SrreD54mLyRRgkbtmTgDFAHAWsRmjMOAs7YVMkAn2NYl3p09pI8ZEe8HnDcZ966a8sWW/Z2A2hsEKOEx61Nq1hZG+U2kjPuUEk9z6ZoAxCki21huVXujwcHOOeDX0v4LheDwtpscud4i5z7kmvOPAvg46jeR3l9Gi2sJBVQMZPp9K9gACgBQABwAO1AC0UUUAFFFFAHK/E7RzrXg2+gjQvPGvnRAdSy8/wAs18t+bMk5haNljz82R/nFfZpAYEMAQeCD3rwzx74IOmak9zBA01lM5Zcc7CexoA878R6j9r02ztrctsijwVB/n+tV9CJudQt2k3ssRwQx4Stl7C3iy727dMKF4z+HenTBkjRbeNYXzjAAHTJ5oA0NB1yRNTl8xR5CsRxwwA/rXoPhm+sY7xruF5CrnIiJzk/T+leZ2tpNeXhiXy4XlwxZ+AWq5f8A2zRIRFvVZi2SV6N3znt+FAHsGlw/8JFdG5aSRYI5CWVyd2fQegrsDEBFsjVQPQjiuD+G2oz3cStNKgRlH1Y49/wrv2IUEnoKAKUsaQRs0u1UJGDu+71p+n31vdh1tnLiI7SSOtc7A93qmvymdG+xrhUhJwCP72a6a2tILUH7PEseeuO9AE9FRSyHd5cfLn9KfGuxAuSfc0AOoqvLM5kMcKgkdTUudiAuRnjJz3oAq3uVmRh6cGrTok8JWRQ0brgqe4NJG6zo2Rlc4+tORdiBQSQPWgD5h+JegTeHPFEiBWNvOTJFJjjFcxJ5kgMjHcBgZ9Pavqbxx4Zg8UaLJaSbVuFG6GUj7rf4V8xavYT6XeyWV0rJNESHU+uSKAMsoLiR42GGGNnvmkbS5hMI98WT0JapG2xyLO+MRkEADk/jVJis947PuO8nG3/CgCWSyWNJBdMuBwcHgfjUBti7O4w3lgHd3xVrU4IoLWGOJ/MctuYdhz603S33zyh5F2unl8nkk0AZsjLcQ/PtTb8oPcc96rxJGwIDyYX5iRwKushWRgV2sDz/AIVBICElKE5kIX+lAGvDPbanaSNdW5e6twCNrfKV9/WqazCd43MSoMghE+tSaBPFp7yzXVvvh8soQ3Rif8/yqBGQ4eMADqpHagCbxHK8+piZSWPCBDnjjpX2T4ZheDw5pcUgw6W0YI9DtFfMHw08OyeK/GloJFzaW7+fcHsMdB+Jr6xACgBQABwAO1AC0UUUAFFFFACMNykHoRivjr4gaY9n4y1SMusflzMQMYLAmvsavlX9ouE2HxB86TeIrmBWGCdpx1oA5Hw1LZxavb3Eke5Y3yR2OB6VX1yZb3UZbpIsRM5OwDBGaopdMsT7YUCk4Bx0ptmSZmZiMkHv3oA1NAu7aLUobq4tvM8twQucA4I6mtvxrrrazqiXhAhVE+QJwB+XtXHRhmld4RgDnH9KnilEjL57BM9uxHuKANyx1+6RVdZst90Bu/fn8K0l1KLUpZJZFZriI7tufv8At/Ksa90MW9ql5H+8tn4Dqe/oarWaKqTj5gSucA8UAejWUkuqxxmTMUart2t0GO3865/Ubm4t9T3NgCMgKqn+eKp6JrEsKyQTszxsmFyfun1qjdpIblY51JOchieo9KANDXLU3ogu1QCVwScetetfAzwY9uza1frg9IVxjn1qT4WeE7HWfDqS3wMirISCOv0ya9bKx2NrHDbIsaKNqKo4UUAfGn7ajBvippeDnGjRA/8Af+evAK94/bIJPxO0wnr/AGPF/wCjp68HoAK+/wD9lsj/AIUV4Z/7ev8A0qlr4Ar7V/Z48Y+GdH+Dnh+21HxNollex/aPMt7i/iilTNxKRlWYHkEH6GgDa/aW8Z3Hh/w9pOkaVq39j6lrF6sRvS5Q28CEF5MjnGSg46gmtv4FeMH8WfDPSNTuZ/Ovo1Npe5OWMsfG8+7LtY/71MuPEvwyvvE9jr+oeI/D0msWcLQW1x/a6YjRs7vkEm3JyecZ7U3Q9Z+Gegz6nPofinw3btqNy13dA6xGQ8rdWAZyFJ9gBQB6Wyx3EZVgsiHqDzXDeKPBm9Gm01N/O4pxuHsPWnR/EbwbG2V8YeHfp/acPP8A49VuD4m+CZAN3i7w6p99ShA/9CoA8yvtEmWd/NDZzgnnK+vBq5oFsY7xEurdWiz8uPTt+dd5feNvh7fIVuvFfhiTtn+1IAfz31iyax8OmV1j8b6EgPTGqwfL9PmoAuS29npN7Bf2ke26jUrtzwwz71S8QeNrW1txBOfs0z8EPyKXWNd8C6jFEq/EHQoWQAFhqduS2B/vCududL+GF9dJNqnj7SLnaMbRq9ugP/j1AHN6fNe6zqT2sEJnd5MFolPTivSPDPw2WKXz9ZlZ1BykKn+ZrR0TxX8NtDt/J0vxP4XgXABK6pAWbHqS+TWl/wALH8D/APQ5eG//AAaQf/FUAdPBDHbwpFCixxoMKqjAAp3OTzx6Vyv/AAsfwR/0OPhv/wAGkH/xdL/wsfwP/wBDl4b/APBpB/8AFUAdVTWDdVIz6EcVy/8AwsfwP/0OXhv/AMGkH/xVH/Cx/A//AEOXhv8A8GkH/wAVQB1KggfMcn6Ypa5X/hY/gf8A6HLw3/4NIP8A4qj/AIWP4H/6HLw3/wCDSD/4qgDqqZNEk0TRyqHRhgqehFcx/wALH8D/APQ5eG//AAaQf/FUf8LH8D/9Dl4b/wDBpB/8VQBl6/4LWOGSXTIlmJyfLb734GvLk0y6GpyCUeWituIcHI9q9l/4WP4H/wChy8N/+DSD/wCKqlf+M/h3fjF34q8LyH+9/acAP576APKZrO4DiWVR5WTj5sH8KS4sBd/MbiPYw/vdK7a9vfhvOQYfG3h+LHY6pAw/Vq5jULDwZdOFT4jeGY4R2GowZx/33QBb8K3Y03U4gHUxxsDyc85617ba3MV1brNbusisMjaa8m0E/DPTGElx420G8lH/AD01WAL+QauxtvH/AICtYVit/F3hiOMdFXU4AP8A0KgDpLKO6DSSXjxlm+6qDhR6ZqW4mEakKRv7D0rkbj4n+C1wIvFvh9ie/wDaUP8A8VUMfj/wXISX8ZeHF9zqcH/xdAHYxzRRqecseWIHU05XllPyDYn948muWj+IHgSPn/hMfDZI7nVID/7NTJfib4LxiPxd4ez6nUoP/iqAOvOyBCT+J7mqpL3GSxCxrzk9BXKSfEXwRHDJcXPjDw/IEUtsTUoWY+wAbP4CvGfiB8ao9fd9O0LUbK0sTlS7XKIWHuSensKAPoXw9r+k6u11Dpd2kzW8pjcZ5JwDkeo56+xrif2lNY1HQfhHql/o17cWN7HLAEngco6gyqDgj1Br5L0TxjGmpTTpfPaSpKRDOr7DgDqeemc16nafFTTte08+HfiHPp+saFOyF2F0Y3G1sglkYHqAaAO8+Fesa1ZfFy/0HW7zxDbWVxpi3Nnp+vTJczyOHw0iyJlVUAMNuec57V3fxL8Cw+J7U3VoFj1SJflbtIB/CawfCF18IPDl4+qaJr3h6G+niEbXF1rQmmCddoMsrMoz1AxXW/8ACx/A/H/FZeG//BpB/wDFUAfMmp2U9rPJZ3iNFLExV0I5BFZsiLHCyrlSflLkcn6V9DeMdS+GfieLNz4u8NRXQHyzpqcG78fm5rxHxJbaNp8jpb+KfD1/AGyrw6lASRn03UAZNzt+zW5A3BU285BzVaEMZV2jcQc4pZda0gIyNqdhtxjidD+XNQprekxWswj1KzDOAObhCcemM0AXL5o5WE0Qb5/vZ7HjpTrGxe5OWyqeuOtRWGqaPlYm1XTdhPzGS5QD9TXcaCfDV5GEuvFXhy129DJqUK/+zUAcNqFqkMgZHdlxjHY0zw7ol/r2rQ2GhpJNK55OPlT3J9K9Li8M+Bp77dqPxE8Nm2DE7YtThDMD77uK9T8N+JPhl4bs/s2j+JvC9vH/ABEanBub3J3c0Aa/w68H23g7QktI9sl2+GuJ8cu3+FdVXK/8LH8D/wDQ5eG//BpB/wDFUf8ACx/A/wD0OXhv/wAGkH/xVAHVUVyv/Cx/A/8A0OXhv/waQf8AxVH/AAsfwP8A9Dl4b/8ABpB/8VQB1VFcoPiR4HJI/wCEy8N8f9ROD/4ql/4WP4H/AOhy8N/+DSD/AOKoA6qvMfjt4Kk8U+Ho7uxXff6eTIqd3TuPr3ro/wDhY/gj/ocfDf8A4NIP/i6X/hY/gf8A6HLw3/4NIP8A4qgD45jDq/lyJkAlNpOMHv8AjV+O1jliLkjyUOHC9d3avVfifo3gDXJJdS8P+MvDFvft8zxHVIAkh/774NeTHUdMtpZLebU9OPON0V3G68e4JFACyMAsKQRLGo+9xkn6mobjdu/dxj5urYzx6VpweI9CttPu4nutPmklRVV/tC5XH41Tk1nQ40AF9ZNvHOJ0JU/nQBq6W8q6HdWf2jd0lVDzwOoxVe0uTHI8gjiwFIPH6VnWmsaXHIzrqtkOMAmdQc/nUb6xppDL/aNjuz8zfaF+b9aALxmRUMgT96rD5U44rpfB2iah4w1qC3tkZYkGZGIOEHcn3qLwPpnhvWH83W/Fmg6dbA9JdShV2+ilq988NeJvhv4c01LPTPFfhiNByzf2nBuc+pO6gDsPD+kW2haVDYWYxFGOp6sfWpp0aebC/dXgnsKwP+Fj+B/+hy8N/wDg0g/+KqFviX4JVwqeLvDhBPJ/tOHA5/3qAPlj9tGNY/ijpSr0/saL/wBHz14FXuH7XWtaVrvxJ0260PU7LUrZdJijaWznSZFcTTEqWUkZwQce4rw+gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAP//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A: CT image reveals multiple large conglomerated masses with air bronchogram. Numerous small nodules have aggregated to form well-defined irregularly marginated nodules of variable size. B: CT image at same level as A, obtained after patient underwent treatment with cyclophosphamide, doxorubicin, vincristine, and prednisone for six months, reveals nodules and masses are smaller and have almost disappeared. However, coarse linear opacities along bronchovascular bundle have become more abundant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Lee JS, Tuder R, Lynch DA. Lymphomatoid granulomatosis: Radiologic features and pathologic correlations. Am J Roentgenol 2000; 175:1335. Reprinted with permission from the American Journal of Roentgenology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33840=[""].join("\n");
var outline_f33_3_33840=null;
var title_f33_3_33841="Cancer incidence in males in more and less developed countries";
var content_f33_3_33841=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66076%7EGAST%2F77893&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66076%7EGAST%2F77893&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 573px\">",
"   <div class=\"ttl\">",
"    Cancer incidence in males in more and less developed countries*",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 553px; height: 449px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Comparison of the most common cancers in more and less developed countries in 2000.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stewart B, Kleihues P. World Cancer Report, IARC Press, Lyon 2003.&nbsp;Copyright &copy; 2003 IARC Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 573px\">",
"   <div class=\"ttl\">",
"    Cancer incidence in females in more and less developed countries*",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 553px; height: 449px; background-image: url(data:image/gif;base64,R0lGODlhKQLBAdUAAP///wAz//8AAAAAABEREYiIiO7u7szMzKqqqlVVVXd3dzMzMyIiIkRERJmZmd3d3f/MzMzW//+qqv9VVVV3/2ZmZru7u/8REXeS/xFB/+7x/4ig/6q7/zNc///d3f93d//u7v+IiP+Zmf8iIpmt//8zM/9ERN3k/yJO/0Rp//9mZrvJ//+7u2aF/wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAApAsEBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vb6/wMHCw8TFxkICycrLzM3Oz9DR0tPU1dbX2NADAdzd3t/g4eLj5OXm5+jp6Me52e7v8PHy89bb6vf4+fr7/Oy49AADChwY0B6/gwgTKjTn7xbBhxAjSkxmcKHFixjvNbQ1saPHj9cqZhxJsuTGWiBTqlwpsqTLlwhPmlEwoOYABgi40EwQ5cOy/xIASjADAUBFshIQhqxcyjRiS5hQo647soIbBwAdvmkQsiHABplMaCoAUGDAAp0DeELx+eFICAFAfYbwcGGE0qZ488p7KrWvX29HTqDIEODqkK4dAGjo9hWsErFkB1QAQLNBgwEGDly+mZNmTQIOhJT9PLpmTic+jyYdMkJAUqFJTbhGpre27Wp8/+qOeqQDBQqFiaAIEOGwV8ePbd4M7bmmAQYMMg8gQMRCzQdlzw7ZSUWEALtCfE4QMkFACADlV99ez75Z7t3wTRZJkRi4YQAYAlAg0rUx8iOQGUDAAAdwB4ADytV0wAEJKHcAgmYpcABlaVEBggAXCAHCBRd4IP+EB0LVJYCHALRnInvvxafiRUVEAM5VGmSQwQn8HfcfgAOMBcACAzhgIIIMFDFgAQYoSFYFNj1g4BMTSACAd+OhJ0BbRXinwl0nZplXiit2GRMS9gkBHAZF9HcjjmM9MGCBFQIg4AAFAPBAA0UOYIF1BA7xwHVlNdCTMhMQxQKGRAkBQTIXnIelloyy5OWjGSURZlUZbCXEYt1kcGYRzZnVWZsAaGYTT6PxSGBzDIT2gKmnkdHoqypxCems6WzKCqy4eiQrrbySY+squQbrVK/E5vOrKsImO9CuxTYbwLGpKCstPcw6Syy0qEyrLTzVWssrtuC+MkC45JZLybjmpqv/riLoruvuu4C0C++89Nohb7345kvFPN16a5G+AD/Cr7+6BWzwIgMT7NfBDB+SsMJSNSzxIA9DDNXEGP9RscUvBWxBBQzUxMCEVKw5RZ0kM1GWWgxvzLF8+iIZJ1l+qoGyxB7IJoAJhQIg22qLvtPvy/oYQUI3KRSXlTdbtcBNB8X9ZzIRonK2o2QMLHBZnNYFuSZ3CJhlwBBhU3eAcwPWdJYDIQ/QwAN1irWyukKxACUAEigDNG3xDE00Pka0QAIAR6dQY2L5bXBCBij8dzZ1RDwX3eNXqx32WTIDYHKDByxAwANElB2qczdb52efddakwNzmXpghABwOkV4RLv+N/1ESR5M5xHBKEwdACr47RjkREDrI48wAhPwAAwSMPfUCPFpQhOhnY3Yzkso1b2RkLJfbWlKxkzcbEbXb/q8RLgYw4xD57QcAcF8BF7VjUwsBZBHHb+d2myY/x2OrQqAe6YyEpMkM4WbcU5cELvCd78hufEFzh9/MN5UjuKhxipERjQBwgqwwLgAbdAzqDkSnIcmJTvkTQvUGcBqTXWZVnyPCngbwgLBhRnN2AkDZJoSABCCQdesyiggeuLcS7YWCJDFCCq5SFQyOyWgBaMGZCtC2kYVqMxVKoRB4FCQhfK1ClxvbELCHvbGV6kCmgtMPQVWut8BliHhbRpT4xi0kjv8kcEgrDqUsBYD0ZcA/GQvkF8pnx4MI8pB3IGQh94HIRs5BkYs0liMn6QZIRlIjlMykGix5yVpp8pNm4GQnzwHKUu7hXqZMpblQqcpWYouVrozlpmApy1o6hpa2zGUetqWN3ejyl1Hg5TMm+CVgGnMJwnQGMQ15zGYiIZnu8aUzp0k+aC5jmf2g5huAWAZu0sKa15SmNr3wsSqmrAjevIIWjZBOWYBTGdhk5Di9kDmaIaGdVVgnOtnoCQgwcGceylkyeDaEtyjKiO+MZ9GQALyo5acbibnUcHQ3Txye84pqm9DcDNCg6YQmbjniqE1mhoA0YhEzzQFNAkMRgvPkzQT/QRGA3QQwngsl46DvpIg4icCBbjg0ABQdQgoIE1RtDu+Aa1JT8+aWv/+lLkeXkV7I7nQT0G0RTkXAE3b4CQrvlMB1QggfAAwawWQqVJJHkJ8QHhoAqAmhBR3oSlGpeVT73eSqDljZDEFHkwrcbIbKKUBfiZBCBjkIn5xYoHkA8D3YvW6si6WjNc8KODAFbwhHa9wGZiTXinoxT0O439Xympa9UsivRjKt/gx41ZkNCWWI1YRRaCoExbYGPJDFaU4pi8m0XvZS6gMAYbwx12mO0AElJJBSDcBUrDp1ezxSSwIQ0DWrAmBrbqoJVQkUW0yUZ0pGEGJBI4tQcPJWHZIK/x4FrnI093EFqJ4VjTkxahaNVkikHs0uaA2APbeBzgFpPAAC0sZctSmou5f4rt7cWAI42hRRkoXmeT1ZhJ52Yz9spQAfAdDZ+GYspwKYcAU9rEsQi5iUJP6liXea4lquuGAtzuWL/xJjGe+WxTXOcR1wqeMeZ4LHPg7yuYRM5E0AuchIXsSRk8xkK+jlxCNusmefHB8pk5jK8LGyh7GMYy1Tk8sw9vI8wUxjMYMBgeH6mRCEsgwQ5K3NZY1VlY/QUMwujaJmMrMR0AytN0NQCG8BSt6AYgQyL6zCPhVCT92rGMboec/b0+F0RoeZsmFvZh0dUPd+MTsiNNbPF4BjhP8dlWXfRg14w8nA4N4LyEfrN2UCrPR0DCC6ylBo077odHhoSwS6jCjOKYEyio2gVuEGQAOL0xSrXR25SMea1pOungF4xByu9kLXG+qQEWADbJAImyGmFsJwaJSVqOWZ2a8mW7Sd82xq33oYui4PlQDwgfPQBbflZcq3y2HZnyqOccZp9aPRvFcbQttszikgABqE6134mbaDukDP/GyCvRm6L0awMDfcB5wAJK3RmUK3fm2CuZqU8dkG2AyPWPuri0dM5HTQ56ZczhuYv2GFWMUWzS9mc2DuHCY99/mW5hx0G+Nl374qes+XrPSmd4HpTo86FqAu9apPgepWz7oTsK7/9a4ngeteT/JEkF7ZsJty7N8y+9klQvbeqv2TaKfV20sZ91nNfQpLqlfdIaVnKtYkAXESnRjy/h81A8CfA/XQwwVQqL0/iqHBOwHwPL4VDSwNBffRZp/sdxbBh4HwYPHzaloaR5gOutBsTztPE42VAKygvX3cT4yUPU6GU005YymNjgZ06dEEHvdCmNNIaaK16Vz0JLoWglfjiChRO95L/W60smVEhMUde56lyRHoBM8dJI1lQAiYIQLq+pwelb9VxKdQzRyTfMUeFAC+JtHzuxR9APBOuLTvoH4864CO3lXwIRMaYeM1BIIyBtgpBTCARMAd2fEfujZbczQE3JZv/wTRdugVbgDAAYQxHBh0NG21YRWlJgQCgD0iaQR4AAaoIJfBE8ejgPpDKmbhgOPzXfNWb/BXF91GLapXBMU2BE4zOF1BeZ5VATrSNQBgHZDTfTliUSlIIMdTfkQSMuhXIQ0YenIkJcsAARQHNPO3IhnnDfsRhB2wakHoaOPkI6NiVZuRezaxewWoICgzYDcRMnFSNXDCgDE4L12oIncHd6knd32YSXtIdIHoSINYaoVoiH9od4moiMMCiI3oYWAXiU43iZSodJZ4iUGXiZpoc5zYiTGmgywCimMmShdIitokiueDil9mihTGis6kigsBi614RKMIi82RANblYq4YZf+geBljcQAEEB2TJFA70zOGN2rZcF5KUGeKMXkpEELn1nRGKARy4zafpSQ2oVKVsTX8Q0PpUjd3I3rVZIuriGjcEDX24SKJgSk24nRAhCAl1DwI0j1a1SkCQo/WBi1g5VhEVI59czvpFTWEsRUFuWxRF4/Y2CD9x0Kh4n+nAioNUgCXAUDk0lhilXyyqBBKoFaLMX3Xx2HvSI13ZY1LGDYNMIyfRSQKsiRdU5LpYlsOJD4W14vDhoEHeZAiKXBFB4yhQgDNIwRtMxZ1sl1s0j1tgzxBJACippE2CW71Zx9VEVE7aXXN8Tb6A1ql0pJsVBaQoy4MBkcPN0cbmRBIoHH/+6cB0Egj7hhctAgA3jcxZVlMb5kFb3J8ATOXzFSXxqSX2cSXQmeOswiYgRmQt0iYRmeY54iYOvaJjJlkjvmYRRaZkilklFmZPnaZmJlKD7FMmylLnbmXn6lKofmXo8mZFSiap0l3qWmaqwlKpSlPPVdOIoOXaMBnSoBg5hKbC9Vz9USRb4Cb+GJ43jFQXNiasikES9MNGsBWbcVk9aNCKjch3YgZNbGGkoZw1uN/3fNsaRODbHOdcKM6OaKbMkGORTFE3gFTyiiYaFUmz5kfxSVkdeUmSQWUBoCPplF+FvBsDaIj07Nu1mMkphMZdIJ75gkWyfck4NWeitmbRXB//2zlVkhWn6JFbQZyMxP5bNjTAAogRgEkoAZwPQmiPVq5j5uia4eCISRCgX7pi/ixf0SQWdAJWnbVRRjaJjezNc9GGZvRRSGqnSNKQJLRbCfacLayoIeCW7z5npeiQUXwkUx2XMl1AMuVoQoiglZ6HQYXWjApJ1zqHDgkPTukQz60PQkqE51mAk4yKEyKnBAqJvAlJuwlo0nmdzcxIVWzANSpoyKTX3Bpcs5hUhdFRmJ6RgA2UmuEpDcylkWhDBWXg0KjmnvEPhcGgjYnnKW4LKr5dpo6Tk1adq8Jm3DqpKMqiKUqqqeKqpzqmqs6SaHqdq8aX5o5q+NUq7ZKTbiaq//OtKu8eky++qut1EtAJ6x+qEw8Z6ysGk3FqqyURKwd46zPOkzJKq2NBK0ugYqet1KmVJw7kxTeGqntiXSQFzUe6HHFYXncgHlRt62xpALquTPpyaDs6aI61axDoHFRIziE43Gxl0G0p3TbujJIKASXERqlwROW5pAS4x3zxqDzhq0ww4O/1a9BZX2YanMDm0UstCdBUhZxsqHKYZEAs6LadniI0qISm0QY2EfcsD5CoH+MVnQbC4MVUBZj0Taj4q4Ns6RE4LPjWq1E0INCcEFC4IEdkLEaO2lDsFFAeRkTEoChw7QNw6YA4KY+06Yzaa8hJrRDUGxLBABNJJJC2K7/VLtSHaUdxGdGCsCzATNb3/qoxgls5IqOGwcATsMNH1eG3MCTMGdDbcg6NoQ8BZA2OOG2sEqt+Gqth7Syd8S416q40Qq5jSu52Uq5lYusi4u5cmm5E8u5kxSsoFtKoju6n1S6pptJqJu6ocu6Nba6rhtI8PS5sfth9/q4tStIs8uyuSu7txspveu7Xcu7lPipofi7AilmD+B/AMoFxgtMySgCbPawCAVlSeCMQuCMzhkc2nR+BuoFz5tL6Jk3EViO1vuF6ahorDcELlIp41QWrPU/9IUT9IVV4ek2Y8Mjm+EncaNpI4e/J/QZamQk4BcZnyFIa9pAoUY7yHuYFDs//+9TsfAzTxM5RmoEHdJBHVKobkGCIGfBI2OxNXWCAG8iPUNwGZPRVAOcJ+BXhYfUaQwEAnTxWHxzvi0bwRDcUxhUezkXqAVQPDZxAG1zs4E6GXWyKliFOgTskHiaFkd8NSzJwiwEIQsgIQg8Pq3hIRNYw7T7tb9FtFmxau9bpFeFAKKlJwpgKhWgcEecP0osxQiQHfnpxNcBxTdTwAXQX7soMZ0mF/fGwMOLu8T2xZeFGJ7lvQ34JnEyJyBaQArowVBsx0uMALa2gslTgnR4yQ7wJq2iWhLjqFgorlhiw6t3YRkIhooxHJk3TstrE6xlh2c6KmNzv3RyNUOZbuCHxP9mUSGdM4clCCEJAH6oEhrD2sCL+XYyFwVaWoukPHfJ3ASlkSqpaMyDGbwYs7uCbM0Ng83Aq80Sw83J680TA7vifDDkXM4Bc87orC/qvM740s7ubCvYUC3xvM0hcYr1nJf3/Ir5rC/zjM/9nC//zM9FBnpCEL73hKJSgLh9uc8wijF1oh0NQrJPUCdiFJ1IYNDpNgQVvARpugQMXZjUQM+NlDohy7AnI6YWFRb7iNBH8NFKENKZJL3JQCU03aAOqrm+6JxUWRXcOy9FMiCfM9H0xacUUnwEcHwW/Vl6Op0mOR0VInxQHcUHUF0T2b/8tDJn00UHmx2XsQAI8NWgo7//15mdl2Y/bVPLDBcyDYAAbH1VGVUv5EsEc4169QDQMVpUgkEYq+wuQV0ZE32XVxqDtlYETxXEgo2fm8cdKhzFbp3UC7fCJDwgJiwaHBt+d9WASHIWFQzC1wUnZXNwJnggMfifl5yzOdS0X/oustEaC9zaGCJqXOu5/FYEExo1vhEm9BLUlwx+F9ojeMjZiqrSa/LbiVptsTzWK2xCkU3VOARAc7MyOJtA3MHYSew2HFqkR9zZzmW/WPSV8BLDMww7jDfeksoMJH0ENEofEdzX68LbgGvGJZmjMKgdRnrRBGLc7rYTT/yEyiHRKzwhBazaagGUykPdFWLdcdIn2W3E/9fB3XFyPEgoYGf7LlkcUxBw4Vs80A8tfenjDe6dLrwd2SyU2M0T3JB2Q0x4nydeIUjCE1JLhyPs2Vc9yUTAOtijFnNT3Rwb4aAtoo9c2t3t4wk4aV5ZL36Mg0mObxx+k3Tar4ym20DNtJxc1H1a3ymO300d1ylnYDzRy9BhfgpSPRZQ43B8421C5pbNEzzOgjehOtlJabOc1mMD4ZGschX+Lt8lrntek3dN0Bm2YVLeYsu8BZDsBM8Mqg7t5E0WzcS8BYluBJFei7iB1wFNL00OlZeOL5le25vO6Yuu6Z+uh6Hu6aMuSPB86uGS6qr+Sq3uSqz+6v4w0qYq67s5Df9DY+vvQuuqquvlwuuy6uvkAuyWXpcyPU3ETtBq59IBCt5U0NGsKQ25HojMPrXOrkuDIgBOwmbKQBTJDqMkcGcxClFKx2e0PJ5wLDqbh1/XXXxgLdbNXTn1dTAeMAIM5CTjRWjfzuiLRgTyGXVoVqBvLOAsVDZh9NlSZSeaLeQnrZRlAaQAUwITUB74LgSNNdvg7Iuopj6Dc9vlHmn99Rl3XPDTQdlgmiAFsOMJXiEVjFzbaDAmABQUPwTicd7TTgQFmWwzGgA73HNopnAHNMmAW6SejOBszvJwMuHHri4rugxOkm0qi+umOm6tNz9SWnRoVqY9pMmcvEMFHF1CMF3/Kn/0PCGy1HHkDDPzUvKw+y7qMfpvjbNeUP7x/41GI0XaaQF+6n4TI9pfbzP271bBeH7t+jLzEdczGE/Npu7F6Dru+qG0wl4Mbb/4kQ8uk590lT/sUt/rmX8slz8Ona/50l7roT9zmx/spb8usZ76/rD6rH8Mrv/6xRD7sj8MtF/7sNDp4ID7nl/qu8/78uz73wD8wf/nmE/8/6H7w4/8N6L8gEGKh81yQeb83YCKS41dFXXT85aMiY/emn6uHyd5egv5AC+mg5VGRh1dPLIAYyPVd+g2l5EZP/opn0HMpUH461LXtaU3AAkEAuGQOBwEkEklEtAEtEgAUiAF6ARW/1OKk9v1fsFh8ZhcNp/RafWa3XajDYOBAbAYILiFAaM+UPQLDBjunBTk5AQZDA4GCLgs5B70Ft4qLS8xM9VMBEYELkScJgQguIpOT4+WVr+mMDQCMpoyZDVtb3FzdXd5u+IOCQqaHBqAAQES/BD2uAwThg8PDw6SpR3kFhQOerm7vc0uBEA8Li5ESU1R1QVUV5W6IpAyTgBQAiIAaL/3+fv9/30hetTowDJHdoQlU7CMT6EBzwBca+iEwIBAcrYVqHDoAUCPH9948gCgBDoAo0o5WaeunTsmXuKhAMAhQwB7MkHm1LmTZ8A5XAwC0HPQIjI/ggg1cdbEQEVhDxr8sv8AacC2Jg8i9dSq9YOAEORGnEvZZCWqli65pOAAYIVNLi0CRNk6l27dW7/ocCk2wA7RhH4AHNhrcWkTwYee6eGL0ZAcBg7sRv43SoCJUhKITFBZtshZd2+TpMC3AUkHuZJRp1a9mnVrfpw7u3znmnZt27dx5x4Dm4hnVrqBBxc+nLg/3kZkJym+nHlz58/FHBfiewl069exZ2ctnV3yl9rBhxc//ht36rPJp1e/nn2uAe3hx5c/3817+vfx56dvX39///+x4w/AAQksEDcBDUxQwQXnQpDBByGMUBezvEtOwgsxzJCsVCqUTcMPQUyQwg4/C9HEE/MbkcTqUGzRRfb/VFxRuRdpZMQRGq+LUcYAcEywsYc6KsPGS5IRBqEev4EgnMpGaoIFISTYLLYdZ3TiCiU0iKAmKuhBMr1i/jiAAEWEbMSWI73kJoQQAMDMhCY8GCGcKDeckkoevyCtAwA22GAmKtIcD5KJDFHgl0KXOSRMM7vYSI4EfpEjKkhuLMaBIquRQw+IKgoyUE1EEKCEJkqYYBQ6AdBRRjDswceJKfb8FLxNnbgmqmj+YGoQB4bUCzAviqmgDwSw4qPIY5oiwIBrIJIVEwnCYdOEUU+Vsrc7v+MCgwC2cIKmAPx0Njtaobm1KqZ+tKhXprJyooBBHhVqgAr0+ONYNIssBg9x/y1RQQjNIDiFTlVX9EIDWrp8Aolu+b1uUIcMxaiJYp5BaF0AfvF0EgOWSraYbe4tCoBBmWn4Dco+8KLaOq/F1gsKAsDACZhjNjk7MAMjQNlfrEIIqQIuBgBnpQZoQOiHmqiGEqOEKUaYJuB92mY2KBtirJVT5dBlLtrKQIOZl3B1aud+bKAjnptAoCIGBgGaUScMcBRIOxaDKNGnj1VboKHG7oVgEvsOnIuNchUcl787NDzwps5V/BbEK3Rc8skvgdw7yjHPPA3LLdTc88+/4NxD0EkvvQsHTU9ddTJQX93115toHfbZTZed9ts9tx333ade57wSeQ8eSd9XFd54Gv+JL/j45VFMHnDmoQfR+cSjHy8oXAoLfvrIq4cu0WgWuP6NoLPnffvLu7/Ojn3Ft6V8zUMVwjIAuhpiVGvtpF5bJfacAgnR0leb9aWtEY4SxiAyMi+DbAQBBqgGASDTq8ZUpFmeU0EoQvWmrqTMC+fr3P5k5gQoSAFQAXTNAAFgEAMEpVAAQOD37nCk9Q1JD0Z73+dClbL6iWosWRNdlZywrdKIjYQhNCFrUBgURsyBEQyABCWuh5UBdMQQFRiSHSBzw8wF7BNNakKowoK/lj2vFW4BQDxikbAjqiaJZloiHYqxqxQySopUnNcVB5BFpJkuYGFsAgg+kY4fZqsLsKj/RRNiskYkJkWJArlGycQnwzsMaSkbqaDmTBClJ4VlAlEKlWbEiBzlcYECa9ECANTCFjMqMjVtdMQboSYy8TlQDhAMjJkMsBc7XDJz/pJfKXY4ARAIUmtkDGISKPA1uPyPiKzMDVaU5czdsKR40gSPFq0ZyulUM5vdhBE1R+lNcZLHg6Mb5znDU060oJOd2VEn8NoZz/DoTp71TA897ZlP8OBTnyaKxj8BGlCBDpSgBTXoQRFK0Nbwsy4JdehDIRpRiTJUdQPgzkUxmlGNcoaiO+noVn6HLZGOlKQu+WjpLLpRla6UpRzVCmzOk5qQlpSmNaXSSUmX0pbulKcrxSkv/2BqzsjM1KZFNapJl6fTni6Vqbz56S6Cuk7JEPWoVT3qU3PXVK1ulSUv5ahQ7UJVq46VpljVnFK5mhkAAHKjUdrhStmEmd54tSwxRY1YaeonDpD0a1eiKT6EmASz0qciVgkD2pzQPlyglU6UKQVbd6oZyGbUrTuNa2fouhK7TnUJW4BFVfXKVyvYFLBLGCx5YCiywo4BsQS8kS4Y24SAqeCPPZWsSivb0svOtSdRhWdYOwuAzx41tCPtK2kBEFgknNZ6fLnlT1YrhtbO8bXuKUKUSqECDwyTrdp1UjhKIQIPzLZJLPAEEVTA3bUKgYNtEgAL6FcZAHhAVPCdb7W6Uv8C+0KgJGyCwEji9AlU1Y9Na3Uvb73xJAFglxOdQJVvf+MELf2PHn5Fwtf8cRbPLsGIe61ZE2DRgRUcUwnh+tpeM7CWJmzraymo2RRa0KUV2OO4MW7CCmqCjxGrMgAibsIJYJaBHX9NuQFgrniWQQlGLK2wkSoaHQ7QF4k5oCJVboJikLbApLAhtiFIScoAqRn60jZgY4HAm56UMgULYVTkuK0OF0w/gAkgFB+4gAfIMSpAuvUCwyzBCEAAggv4VwBqfi8AODESExh6t0b4RpzmBABP/DeQLFNnF/r0pyo4QU8A0bBwlSCzba0FAzJDIxLoQTMOqzK0I3YxPVLgJ9L/VLgKbZFZW/q6hRMEoAVnvAefsJDceZwgA3uCBal/XeQjhye1T4vuxOblwgFYgGdNXKGZ9PCXAsBwX1y+LgBCoBkJ3BaDlR4BMIUQCi5Mlk2fXK8Xm4CZkYxguxegbRdK4Fba0hcdKrisnv3ohA9k1ysHdrQ3SlWtUZggBAK4tw81C9ZX9ZgLrfJ0cIcbADXOpNdn3MAVukSCIuMDLnrFibb2dII9xeM0IA5AX6MwhVqgoLS37jgXYmVxZS8oyU040mrfhRiGYIwx0Q4KvIT+tvp8u+H/Wm+5zSFpdNMZAPE7RbsFcNuR+HIIbIIvZvb97Q+Evd+XfRMIwnheIRC8/9HT8ca0ThJnLnZC3RC/tBe+Fa7kcssjn844PZaZBAycBgUo2ICr/IcEkoNrJjixhxJ0vPeYLwHmJJx5zdnS610nYebJNi3PnQuAKgKgsBtzxtB5Nvqj5xEoSm9Dl4dwWzE7HABljm/W11qSTqp1zOv1bzg+0PD7xb3P8R0BCy7AZz8DWtCXDQVmLgOlCTjf4G7nxtyHIAE5tSkcTYIwi0DDdxAjrO8YL/EZa4IB0iDB8UmYfBJCG4W94sPDHIBZCA/Gdw1coZQvt4Kuec3XSguwvGbvUADHSosedk5Beu4YCssQjIZiGOcApKggmOEaHMEQFoAOCmAhXM/biCBKmv8O97qrvMDr9hxuLN6K6mpvvQptmO5r7ebLfuzLvSpLv2Srv+bruz6h7szrAvar+tiBH6qlHOZNALzvq6SqCWjGiADg/j7i07iANF7hxyhA706gBQ5pJrZEHnaM/mLhNGYsFk4sCVpAbFhstGyMLXIMALpk/XysCfaqA+jhBBTw8xgwGoKhCQrrAehmlyICGyTGUfriyipiDxBAsUAwrRixCNouo5bNDKpFAkpCVB5MCX9L1RSvazDs4sjqE92htEgqEhUHrRqRER8Ro0jREr4PPYYKFGER8vZuFJPqFG2Rp1axEloRiIArFn2xpnIxcEzxFonxooLRDXaRkBrqF5n/kRaPZxiLMRphKrPujrOa8RpvqhalcRuP4xjbIBnxxBqxcRw7xBunBhq5MR0RbCfAUabI8R29wxxtBh3VUR3l8RbucRfwCh5/MR/5ZaIAMiAFMqIW6jYG8iARMiH7yUv8cSEdskEeMiL3SSLFJSEt8iIxMiM1ciM5siM9MqHECZ9EsgxGknVI8iRRcgxKUiVTUgxW0iXN4CXDQCbBgCa/wCZvMiRbciZ3siZ7MidN8ie9ACdPRyiLMihZ0ii5gCiXUimdgCmfMiZ1Eilhkip50ip9EiuzMim5siq78iq/civDEijHciidMnbOEgD4qSHPKi2hEi210izjUi7L8ijr/7Ip5xIv71IvvbIvwdIvxfIvBXMwnekt1dItETMv+ZIw6RIwydIxG5MxIzMwKfMxJXMxK3MyM1ORDLMzE3Mvo1Ix4RI0D1M0S5M0TxMy7VI1MdMyN7M1XbMwP5M1Q5M0DTM1L7M2aXM0dxM3XxM2VzM3eVM4fTM2NdM4KTI5lXM5mbM5nfM5oTM6pXM6qbM6rfM6sRMXBmPaRqbKLKAJLMA7QYKWGgEyjuYQvjM8G+E750I9CYA9tYI8bek85SA9xRMkttM+1xM87zM7J0Zq+FAYCuBG9nBAQcIPt8EQ/rMLCrS6eqJB5wJBRc8+GgBASU9AHfQfKpRBMTRAhSJDr/9zQ52AEZ5yGvijcXLCAhpCRA3jRA2LJ0g0dl50K1R0QUfURfETQGNULU20RP0T2jQlIiaCARDAAYa020CiAoJkMITBSJ2ASLfCSaEGSbdCSYG0KKTUhajUH5hUSJ+0SI/0R7ngGg4gS4nUTLf0H4DGC8gUTaM0TOliTbugTeE0J+j0S91UTJ/SAmI0DnqU6GZUQ9NULfnUPvx0K/oURbWiAQZ12hI1UPuuUNnlTw/VP/2wIwaUDiD0Qj/0QBcAQC/1QzW1Q+diU7XCD0F1ATA1mkwVIEI1UznVQGMVRKszlxyDPd0TV/sTIKjiEBzAVvdAV/ezPXeVJ3pVDn51L5z/iD+H1SOAdVm7c1hzVU+ptVqt9VqxNVu1dVu5tVu99VvBNVzFdVzJtVzN9VzRNV3V9UKwyQ0U0RvadV355ReWJhkGlQzi9QzQ5l27IV/lVVYi5S/udQz8tQz29QPhdY/+dWzioMoewF7RpiIQwEaSgQAQoGLxQAPjaBvIsyggsBjygkEPIXwKKEjlRQ7+IGIJwUilAYb+QMtEZoKQ5jBMdmEBthEgEGIlRmJtZFkawQBqaEIpIWiL4TsHwQLSJWS54GCVhYWQhnBUdmJ/1guQwgFUKCiCdikGYWBttkcaVtokNmqHJCic9hlsRIqioQMV9guY9rmqdo4UYWfvQIoI6kABIINj0raR5gCLJvQZ4IVeutZZvvZ7GkhupdYRyNZMloJS6qgZ1pZqJUZv35YhojaFFOAQiQFpEEJy+XYpHkAB6EZYAjdQvtYoCGFXGOdwqWt1K0lz9ygBECB7nEZkv1NyW/cPUFdiuWBXfKZtbPdp13YjRHd0vaR0UzcQH4JnzSRxM7ARJIUO4uYQzCZ7xsQLFINkX2lvFAUakvcOYEgY9IZtLEJygXWXnAxSiDd6IMFC03db36V94Td+5Xd+6bd+7fd+8Td/9Xd/+bd//fd/ATiABXiACbiADfiAETiBFXiBGbiBzTUIAAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Comparison of the most common cancers in more and less developed countries in 2000.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stewart B, Kleihues P. World Cancer Report,&nbsp;IARC Press, Lyon 2003. Copyright &copy; 2003 IARC Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33841=[""].join("\n");
var outline_f33_3_33841=null;
var title_f33_3_33842="Juvenile angiofibroma";
var content_f33_3_33842=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F76702&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F76702&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Axial CT and endoscopic nasal view of a juvenile angiofibroma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 267px; height: 514px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This juvenile angiofibroma was a cause of repeated epistaxis in this teenage boy. Axial computed tomography with contrast shows a vascular mass arising from the pterygopalatine fossa and filling the nasopharynx (black arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn Isaacson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33842=[""].join("\n");
var outline_f33_3_33842=null;
var title_f33_3_33843="Abdomen aorta flow reversal AR";
var content_f33_3_33843=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55026&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55026&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 519px\">",
"   <div class=\"ttl\">",
"    Diastolic flow reversal in the descending abdominal aorta in aortic regurgitation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 499px; height: 353px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Using a subcostal window, just to the left of the midline, the pulse wave Doppler (PWD) sample volume from the abdominal aorta (ABAO) viewed in its long axis (panel A). In severe aortic regurgitation, the reverse diastolic flow component is almost equal in size to the forward flow signal (panel B). However, the net forward flow is actually greater than the reversed flow because the diameter of the aorta in systole is much larger than in diastole, due to augmented pulsitility. In the normal subject, diastolic flow in the aorta is minimal (panel C); there is a prominent forward flow signal above the baseline and a small and brief signal of reversed diastolic flow below (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33843=[""].join("\n");
var outline_f33_3_33843=null;
var title_f33_3_33844="Miconazole (topical): Pediatric drug information";
var content_f33_3_33844=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Miconazole (topical): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?22/50/23334?source=see_link\">",
"    see \"Miconazole (topical): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/27/4533?source=see_link\">",
"    see \"Miconazole (topical): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F196307\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      3M&trade; Cavilon&trade; Antifungal [OTC];",
"     </li>",
"     <li>",
"      Aloe Vesta&reg; Antifungal [OTC];",
"     </li>",
"     <li>",
"      Baza&reg; Antifungal [OTC];",
"     </li>",
"     <li>",
"      Carrington&reg; Antifungal [OTC];",
"     </li>",
"     <li>",
"      Critic-Aid&reg; Clear AF [OTC];",
"     </li>",
"     <li>",
"      DermaFungal [OTC];",
"     </li>",
"     <li>",
"      Dermagran&reg; AF [OTC];",
"     </li>",
"     <li>",
"      DiabetAid&reg; Antifungal Foot Bath [OTC];",
"     </li>",
"     <li>",
"      Fungoid&reg; [OTC];",
"     </li>",
"     <li>",
"      Lotrimin AF&reg; [OTC];",
"     </li>",
"     <li>",
"      Micaderm&reg; [OTC];",
"     </li>",
"     <li>",
"      Micatin&reg; [OTC];",
"     </li>",
"     <li>",
"      Micro-Guard&reg; [OTC];",
"     </li>",
"     <li>",
"      Miranel AF&trade; [OTC];",
"     </li>",
"     <li>",
"      Mitrazol&reg; [OTC];",
"     </li>",
"     <li>",
"      Monistat&reg; 1 Day or Night [OTC];",
"     </li>",
"     <li>",
"      Monistat&reg; 1 [OTC];",
"     </li>",
"     <li>",
"      Monistat&reg; 3 [OTC];",
"     </li>",
"     <li>",
"      Monistat&reg; 7 [OTC];",
"     </li>",
"     <li>",
"      Neosporin&reg; AF [OTC];",
"     </li>",
"     <li>",
"      Podactin Cream [OTC];",
"     </li>",
"     <li>",
"      Secura&reg; Antifungal Extra Thick [OTC];",
"     </li>",
"     <li>",
"      Secura&reg; Antifungal Greaseless [OTC];",
"     </li>",
"     <li>",
"      Ting&reg; Spray Powder [OTC];",
"     </li>",
"     <li>",
"      Zeasorb&reg;-AF [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F196308\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dermazole;",
"     </li>",
"     <li>",
"      Micatin&reg;;",
"     </li>",
"     <li>",
"      Micozole;",
"     </li>",
"     <li>",
"      Monistat&reg;;",
"     </li>",
"     <li>",
"      Monistat&reg; 3",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1048641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antifungal Agent, Topical",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antifungal Agent, Vaginal",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1048634\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?22/50/23334?source=see_link\">",
"      see \"Miconazole (topical): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants, Children, Adolescents, and Adults: Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tinea pedis and tinea corporis: Apply twice daily for 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tinea cruris: Apply twice daily for 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adolescents and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vaginal: Insert contents of 1 applicator of 2% vaginal cream or 100 mg vaginal suppository at bedtime for 7 days; or 1 applicator of 4% vaginal cream or 200 mg vaginal suppository at bedtime for 3 days; or 1200 mg vaginal suppository one-time dose at bedtime or during the day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Many products are available as a combination pack (contains a suppository for vaginal instillation and external cream which is applied twice daily for up to 7 days to relieve external symptoms)",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F196288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Aerosol, powder, topical, as nitrate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lotrimin AF&reg;: 2% (133 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lotrimin AF&reg;: 2% (133 g) [deodorant formulation]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Micatin&reg;: 2% (90 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neosporin&reg; AF: 2% (85 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ting&reg; Spray Powder: 2% (128 g) [contains aloe, ethanol 10% w/w]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Aerosol, spray, topical, as nitrate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Micatin&reg;: 2% (90 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Micatin&reg;: 2% (105 mL) [contains benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neosporin&reg; AF: 2% (105 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Combination package, topical/vaginal, as nitrate: Cream, topical: 2% (9 g) and Suppository, vaginal: 200 mg (3s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Monistat&reg; 3: Cream, topical: 2% (9 g) and Insert, vaginal: 200 mg (3s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Monistat&reg; 7: Cream, topical: 2% (9 g) and Cream, vaginal: 2% (45 g), Cream, topical: 2% (9 g) and Cream, vaginal: 2% (7 x 5 g) [contains benzoic acid]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Monistat&reg; 3: Cream, topical: 2% (9 g) and Cream, vaginal: 4% (25 g), Cream, topical: 2% (9 g) and Cream, vaginal: 4% (3 x 5 g) [contains benzoic acid; vaginal cream 200 mg/applicator]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Monistat&reg; 7: Cream, topical: 2% (9 g) and Suppository, vaginal: 100 mg (7s) [contains benzoic acid (in cream)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Monistat&reg; 1: Cream, topical: 2% (9 g) and Insert, vaginal: 1200 mg (1) [contains benzoic acid (in cream), soya lecithin (in insert)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Monistat&reg; 1 Day or Night: Cream, topical: 2% (9 g) and Insert, vaginal: 1200 mg (1) [contains benzoic acid (in cream), mineral oil (in insert), soya lecithin (in insert)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, topical, as nitrate: 2% (15 g, 30 g, 45 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Baza&reg; Antifungal: 2% (4 g, 57 g, 142 g) [zinc oxide based formula]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Carrington&reg; Antifungal: 2% (150 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Micaderm&reg;: 2% (30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Micatin&reg;: 2% (14 g) [contains benzoic acid]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Micro-Guard&reg;: 2% (60 g [DSC])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miranel AF&trade;: 2% (28 g) [contains ethanol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3M&trade; Cavilon&trade; Antifungal: 2% (56 g, 141 g) [contains castor oil]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neosporin&reg; AF: 2% (14 g, 15 g) [contains benzoic acid]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Podactin Cream: 2% (30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Secura&reg; Antifungal Extra Thick: 2% (97.5 g) [contains zinc oxide]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Secura&reg; Antifungal Greaseless: 2% (60 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cream, vaginal, as nitrate: 2% (45 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Monistat&reg; 7: 2% (45 g) [contains benzoic acid; 100 mg/applicator]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Monistat&reg; 3: 4% (15 g, 25 g) [contains benzoic acid; 200 mg/applicator]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, topical, as nitrate [spray]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lotrimin AF&reg;: 2% (150 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ointment, topical, as nitrate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Aloe Vesta&reg; Antifungal: 2% (60 g, 150 g) [contains aloe]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Critic-Aid&reg; Clear AF: 2% (57 g, 142 g, 300s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     DermaFungal: 2% (120 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermagran&reg; AF: 2% (120 g) [zinc oxide based formula]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder, topical, as nitrate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Lotrimin AF&reg;: 2% (90 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Micro-Guard&reg;: 2% (90 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mitrazol&reg;: 2% (30 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zeasorb&reg;-AF: 2% (70 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Suppository, vaginal, as nitrate: 100 mg (7s); 200 mg (3s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet for solution, topical, as nitrate [effervescent]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     DiabetAid&reg; Antifungal Foot Bath: 2% (10s)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tincture, topical, as nitrate:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Fungoid&reg;: 2% (7.39 mL, 30 mL) [contains isopropyl alcohol 30%]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F196276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Cream (topical and vaginal), vaginal suppository",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1048644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For external use only.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Topical: Apply sparingly to the cleansed, dry affected area; if intertriginous areas are involved, rub cream gently into the skin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Vaginal: Wash hands before using; gently insert tablet or full applicator of cream high into vagina at bedtime. Wash applicator with soap and water following use. Remain lying down for 30 minutes following administration.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1048637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at room temperature",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1048643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of vulvovaginal candidiasis; topical treatment of superficial fungal infections",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F196356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Miconazole may be confused with metroNIDAZOLE, Micronase, Micronor&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Lotrimin&reg; may be confused with Lotrisone&reg;, Otrivin&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Micatin&reg; may be confused with Miacalcin&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F196355\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Topical: Allergic contact dermatitis, burning, maceration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Vaginal: Abdominal cramps, burning, irritation, itching",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1048647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to miconazole or any component; vaginal preparation should not be used in the first trimester of pregnancy unless the drug is essential to patient's welfare",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1048633\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients allergic to other imidazole-derivative antifungals (eg, clotrimazole, econazole, ketoconazole)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1048632\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The safety of miconazole in infants &lt;1 year of age has not been established",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F196346\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F196284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Miconazole (Topical) may increase the serum concentration of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13825032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Following vaginal administration, small amounts are absorbed systemically. Adverse fetal events have not been observed and vaginal products may be considered for the treatment of vulvovaginal candidiasis in pregnant women (CDC, 2010; Czeizel, 2004; Stevens, 2002).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1048640\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hematocrit, hemoglobin, serum electrolytes and lipids",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1048631\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits biosynthesis of ergosterol, damaging the fungal cell wall membrane which increases permeability and causes leaking of nutrients",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1048646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Vaginal: Small amount absorbed systemically",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Into body tissues, joints, and fluids; poor penetration into sputum, saliva, urine, and CSF",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 91% to 93%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: In the liver",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: Multiphasic degradation:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Alpha: 40 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Beta: 126 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Terminal: 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: &sim;50% excreted in feces and &lt;1% in urine as unchanged drug",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1048639\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/27/4533?source=see_link\">",
"      see \"Miconazole (topical): Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid contact with the eyes; do not use vaginal cream or suppositories for self-medication if patient has abdominal pain, fever, or malodorous vaginal discharge; inform physician if abdominal pain, hives, skin rash, vaginal pruritus or discomfort occurs; avoid intercourse during therapy if using vaginal product. Condoms and diaphragms may not be effective if using vaginal product. Do not use tampons, douches, spermicides, or other vaginal products during treatment. Use deodorant-free sanitary napkins or pads instead.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12610 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-FA3CAE7412-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33844=[""].join("\n");
var outline_f33_3_33844=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196307\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196308\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048641\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048634\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196288\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196276\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048644\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048637\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048643\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196356\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196355\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048647\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048633\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048632\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196346\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F196284\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13825032\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048640\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048631\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048646\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048639\">",
"      Patient Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12610\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12610|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?22/50/23334?source=related_link\">",
"      Miconazole (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?4/27/4533?source=related_link\">",
"      Miconazole (topical): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_3_33845="Chronic rejection Light III";
var content_f33_3_33845=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F65391&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F65391&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Light micrograph showing late stage chronic renal transplant rejection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power light micrograph in chronic rejection reveals marked tubular dropout and interstitial fibrosis (in the area between the glomeruli). These findings represent the end-stage of a process induced by ischemia from the associated vascular lesions and repeated episodes of interstitial inflammation (acute cellular rejection).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33845=[""].join("\n");
var outline_f33_3_33845=null;
var title_f33_3_33846="Paclitaxel: Pediatric drug information";
var content_f33_3_33846=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Paclitaxel: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"    see \"Paclitaxel: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?17/26/17829?source=see_link\">",
"    see \"Paclitaxel: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F205582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Paclitaxel&reg;;",
"     </li>",
"     <li>",
"      Paclitaxel for Injection;",
"     </li>",
"     <li>",
"      Paclitaxel Injection USP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1049103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antineoplastic Agent, Antimicrotubular",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1049096\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"      see \"Paclitaxel: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V. infusion (refer to individual protocols):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Treatment for refractory leukemia is still undergoing investigation: 250-360 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose infused over 24 hours every 14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Recurrent Wilms' tumor: 250-350 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose infused over 24 hours every 3 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ovarian carcinoma: 135-175 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose infused over 1-24 hours every 3 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Metastatic breast cancer: 175 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose infused over 3 hours every 3 weeks (protocols have used dosages ranging between 135-250 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose over 1-24 hours every 3 weeks)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kaposi's sarcoma: 135 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose infused over 3 hours every 3 weeks, or 100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose infused over 3 hours every 2 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"     None",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Total bilirubin &le;1.5 mg/dL and AST &gt;2x normal limits: Total dose &lt;135 mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Total bilirubin 1.6-3.0 mg/dL: Total dose &le;75 mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Total bilirubin &ge;3.1 mg/dL: Total dose &le;50 mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F205555\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 6 mg/mL (5 mL, 16.7 mL, 25 mL, 50 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F205541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1049107\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Parenteral: I.V.: Patients should be premedicated with a corticosteroid, diphenhydramine and an H",
"     <sub>",
"      2",
"     </sub>",
"     -receptor antagonist 30-60 minutes prior to paclitaxel administration. To minimize patient exposure to the plasticizer diethylhexylphthalate (DEHP) from polyoxyl 35 castor oil-induced leaching of polyvinyl chloride-containing I.V. infusion bags and administration sets, prepare paclitaxel infusions in glass or in polypropylene or polyolefin bags and administer through polyethylene lined administration sets with a 0.22 micron in-line filter. Paclitaxel can be further diluted in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS or D",
"     <sub>",
"      5",
"     </sub>",
"     in Ringer's injection to a final concentration of 0.3-1.2 mg/mL. Paclitaxel has been infused over short (1-3 hours) and long periods (24, 72, and 96 hours to 14 days continuous infusion)",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F205634\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, amikacin, aminophylline, ampicillin/sulbactam, anidulafungin, bleomycin, butorphanol, calcium chloride, carboplatin, cefepime, cefotetan, ceftazidime, cimetidine, cisplatin, cladribine, cyclophosphamide, cytarabine, dacarbazine, dexamethasone sodium phosphate, diphenhydramine, doripenem, doxorubicin, droperidol, etoposide, etoposide phosphate, famotidine, floxuridine, fluconazole, fluorouracil, furosemide, ganciclovir, gemcitabine, gentamicin, granisetron, haloperidol, heparin, hydrocortisone sodium phosphate, hydrocortisone sodium succinate, hydromorphone, ifosfamide, linezolid, lorazepam, magnesium sulfate, mannitol, meperidine, mesna, methotrexate, metoclopramide, morphine, nalbuphine, ondansetron, ondansetron with ranitidine, oxaliplatin, palonosetron, pemetrexed, pentostatin, potassium chloride, prochlorperazine edisylate, propofol, ranitidine, sodium bicarbonate, thiotepa, topotecan, vancomycin, vinblastine, vincristine, zidovudine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amphotericin B, amphotericin B cholesteryl sulfate complex, chlorpromazine, doxorubicin liposome, hydroxyzine, methylprednisolone sodium succinate, mitoxantrone.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ceftriaxone.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Incompatible:",
"     </b>",
"     Ceftriaxone.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1049099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refrigerate intact vials or store at room temperature; undiluted vials of paclitaxel may precipitate upon refrigeration, but will redissolve at room temperature with no loss in potency; dilution of paclitaxel from 0.3 mg/mL to 1.2 mg/mL in NS or D",
"     <sub>",
"      5",
"     </sub>",
"     W is stable for up to 48 hours at room temperature; incompatible with amphotericin B, chlorpromazine, hydroxyzine, methylprednisolone, and mitoxantrone",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1049106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of breast cancer, advanced ovarian cancer, nonsmall cell lung cancer, and second-line treatment of AIDS-related Kaposi's sarcoma (FDA approved in adults); has also been used in head and neck cancer, bladder cancer, cervical cancer, small cell lung cancer, and unknown  primary adenocarcinomas",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F205636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       PACLitaxel may be confused with cabazitaxel, DOCEtaxel, PARoxetine, Paxil&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       PACLitaxel (conventional) may be confused with PACLitaxel  (protein-bound)",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Taxol&reg; may be confused with Abraxane&reg;, Paxil&reg;, Taxotere&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F205633\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Myelosuppression is dose related, schedule related, and infusion-rate dependent (increased incidences with higher doses, more frequent doses, and longer infusion times) and, in general, rapidly reversible upon discontinuation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiovascular: Bradycardia, ECG abnormal, edema, flushing, hyper-/hypotension, rhythm abnormalities, syncope, tachycardia, venous thrombosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dermatologic: Alopecia, nail changes, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Abdominal pain (with intraperitoneal paclitaxel), diarrhea, mucositis, nausea/vomiting, stomatitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hematologic: Anemia, bleeding, febrile neutropenia, leukopenia; neutropenia (onset 8-10 days, median nadir 11 days, recovery 15-21 days); thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hepatic: Alkaline phosphatase increased, AST increased, bilirubin increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Local: Injection site reaction (erythema, tenderness, skin discoloration, swelling)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Arthralgia/myalgia, peripheral neuropathy, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Renal: Creatinine increased (observed in KS patients only)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Miscellaneous: Hypersensitivity reaction, infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Anaphylaxis, arrhythmia, ataxia, atrial fibrillation, AV block, back pain, cardiac conduction abnormalities, cellulitis, CHF, chills, conjunctivitis, dehydration, enterocolitis, extravasation recall, hepatic encephalopathy, hepatic necrosis, induration, intestinal obstruction, intestinal perforation, interstitial pneumonia, ischemic colitis, lacrimation increased, maculopapular rash, malaise, MI, myocardial ischemia, necrotic changes and ulceration following extravasation, neuroencephalopathy, neutropenic enterocolitis, neutropenic typhlitis, ototoxicity (tinnitus and hearing loss), pancreatitis, paralytic ileus, phlebitis, pneumonitis, pruritus, pulmonary embolism, pulmonary fibrosis, radiation recall, radiation pneumonitis, renal insufficiency, seizure, skin exfoliation, skin fibrosis, skin necrosis, Stevens-Johnson syndrome, supraventricular tachycardia, toxic epidermal necrolysis, ventricular tachycardia (asymptomatic), visual disturbances (scintillating scotomata)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1049110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to paclitaxel, Cremophor&reg; EL (polyoxyethylated castor oil) or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1049095\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with moderate or severe hepatic impairment; dosage adjustment may be necessary in patients with hepatic impairment, severe neutropenia, or peripheral neuropathy. Formulations contain dehydrated alcohol; may cause adverse CNS effects. Should be administered under the supervision of an experienced cancer chemotherapy physician",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1049094\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     . Anaphylaxis and severe hypersensitivity reactions have occurred in 2% to 4% of patients receiving paclitaxel in clinical trials during first or subsequent infusions",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     .",
"     <b>",
"      All patients should be premedicated with a corticosteroid, diphenhydramine, and an H",
"      <sub>",
"       2",
"      </sub>",
"     </b>",
"     -",
"     <b>",
"      receptor antagonist to prevent hypersensitivity reactions;",
"     </b>",
"     fatal reactions have occurred despite premedication. Patients who experience severe hypersensitivity reactions to paclitaxel should not be rechallenged with the drug. Be prepared to treat a severe hypersensitivity reaction with epinephrine, I.V. fluids, diphenhydramine, and a corticosteroid.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     CNS toxicity has been reported in pediatric patients receiving high doses of paclitaxel (350-420 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     as a 3-hour infusion) which may have resulted from the ethanol contained in the formulation. With use, peripheral neuropathy may occur; patients with pre-existing neuropathies from chemotherapy or coexisting conditions (eg, diabetes mellitus) may be at a higher risk; reduce dose by 20% for severe neuropathy. Severe bone marrow suppression (primarily neutropenia) with resulting infection may occur",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . In general, do not administer paclitaxel to patients with baseline neutrophil counts &lt;1500/mm",
"     <sup>",
"      3",
"     </sup>",
"     (&lt;1000 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     for patients with AIDS-related KS). Infusion-related hypotension, bradycardia, and/or hypertension may occur; frequent monitoring of vital signs is recommended, especially during the first hour of the infusion. Rare but severe conduction abnormalities have been reported; conduct cardiac monitoring during subsequent infusions for these patients.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F205622\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2C8 (major), CYP3A4 (major), P-glycoprotein;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Induces",
"     </b>",
"     CYP3A4 (weak/moderate)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F205549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antineoplastic Agents (Anthracycline, Systemic): Taxane Derivatives may enhance the adverse/toxic effect of Antineoplastic Agents (Anthracycline, Systemic). Taxane Derivatives may increase the serum concentration of Antineoplastic Agents (Anthracycline, Systemic). Taxane Derivatives may also increase the formation of toxic anthracycline metabolites in heart tissue.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inducers may decrease the serum concentration of ARIPiprazole.  Management: Double the oral aripiprazole dose and closely monitor clinical response.  Reduce the oral aripiprazole dose to 10-15 mg/day if the inducer is discontinued. Avoid use of CYP3A4 inducers for more than 14 days with extended-release injectable aripiprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Axitinib: CYP3A4 Inducers (Weakly to Moderately Effective) may decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bexarotene (Systemic): May decrease the serum concentration of PACLitaxel. PACLitaxel may increase the serum concentration of Bexarotene (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C8 Inducers (Strong): May increase the metabolism of CYP2C8 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C8 Inhibitors (Moderate): May decrease the metabolism of CYP2C8 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2C8 Inhibitors (Strong): May decrease the metabolism of CYP2C8 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP2C8 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     DOXOrubicin: Taxane Derivatives may decrease the metabolism of DOXOrubicin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP2C8 Substrates. Management: Use CYP2C8 substrates at the lowest recommended dose, and monitor closely for adverse effects (including myopathy), during and in the 2 weeks following mifepristone treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inhibitors: May increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Platinum Derivatives: May enhance the myelosuppressive effect of Taxane Derivatives. Administer Taxane derivative before Platinum derivative when given as sequential infusions to limit toxicity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Reverse Transcriptase Inhibitors (Non-Nucleoside): May decrease the metabolism of PACLitaxel.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inducers may decrease the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SORAfenib: May enhance the adverse/toxic effect of PACLitaxel. Management: Concurrent sorafenib with carboplatin and paclitaxel in patients with squamous cell lung cancer is contraindicated.  Use in other settings is not specifically contraindicated but should be approached with added caution.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: PACLitaxel may increase the serum concentration of Trastuzumab. Trastuzumab may decrease the serum concentration of PACLitaxel.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vinorelbine: PACLitaxel may enhance the neurotoxic effect of Vinorelbine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F205551\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F205566\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events (embryotoxicity, fetal toxicity, and maternal toxicity) have been observed in animal reproduction studies at doses less than the recommended human dose. An",
"     <i>",
"      ex vivo",
"     </i>",
"     human placenta perfusion model illustrated that paclitaxel crossed the placenta at term. Placental transfer was low and affected by the presence of albumin; higher albumin concentrations resulted in lower paclitaxel placental transfer (Berveiller, 2012). Women of childbearing potential should be advised to avoid becoming pregnant. A pregnancy registry is available for all cancers diagnosed during pregnancy at Cooper Health (877-635-4499).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1049102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with differential, platelet count, vital signs, ECG, liver function test; observe I.V. injection site for extravasation",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1049093\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilizes microtubules by preventing depolymerization; results in the inhibition of mitotic cellular functions and cell replication by blocking cells in the late G2 phase and M phase of the cell cycle",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1049109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Biphasic with initial rapid distribution to the peripheral compartment; later phase is a slow efflux of paclitaxel from the peripheral compartment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     V",
"     <sub>",
"      d",
"     </sub>",
"     : 227-688 L/m",
"     <sup>",
"      2",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 89% to 98%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Cytochrome P450 hepatic isoenzymes metabolize paclitaxel to 6 alpha-hydroxypaclitaxel",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life (varies with dose and infusion duration):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 4.6-17 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 1.5-8.4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urinary recovery of unchanged drug: 1.3% to 12.6%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: No significant drug removal by hemodialysis",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1049101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?17/26/17829?source=see_link\">",
"      see \"Paclitaxel: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid alcohol; may cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Woo MH, Gregornik D, Shearer PD, et al, &ldquo;Pharmacokinetics of Paclitaxel in an Anephric Patient,&rdquo;",
"      <i>",
"       Cancer Chemother Pharmacol",
"      </i>",
"      , 1999, 43(1):92-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33846/abstract-text/9923547/pubmed\" id=\"9923547\" target=\"_blank\">",
"        9923547",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12671 Version 46.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-122.72.80.101-1C61674EA5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33846=[""].join("\n");
var outline_f33_3_33846=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709191\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205582\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049103\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049096\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205555\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205541\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049107\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205634\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049099\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049106\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205636\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205633\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049110\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049095\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049094\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205622\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205549\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205551\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F205566\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049102\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049093\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049109\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049101\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12671\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12671|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=related_link\">",
"      Paclitaxel: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?17/26/17829?source=related_link\">",
"      Paclitaxel: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_3_33847="Division of uterosacral ligms";
var content_f33_3_33847=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F75541&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F75541&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 529px\">",
"   <div class=\"ttl\">",
"    Opening the rectovaginal space during hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 509px; height: 411px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Opening the rectovaginal space allows clamping and division of uterosacral ligaments.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33847=[""].join("\n");
var outline_f33_3_33847=null;
var title_f33_3_33848="Fetal circulation";
var content_f33_3_33848=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55037&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55037&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 515px\">",
"   <div class=\"ttl\">",
"    Schematic diagram of the human-fetal circulation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 495px; height: 639px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The degree of oxygen saturation is indicated by shading, as explained in the figure key.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33848=[""].join("\n");
var outline_f33_3_33848=null;
var title_f33_3_33849="Verapamil: Pediatric drug information";
var content_f33_3_33849=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Verapamil: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"    see \"Verapamil: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?5/53/5974?source=see_link\">",
"    see \"Verapamil: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F233861\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Calan&reg;;",
"     </li>",
"     <li>",
"      Calan&reg; SR;",
"     </li>",
"     <li>",
"      Covera-HS&reg; [DSC];",
"     </li>",
"     <li>",
"      Isoptin&reg; SR;",
"     </li>",
"     <li>",
"      Verelan&reg;;",
"     </li>",
"     <li>",
"      Verelan&reg; PM",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F233862\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Verap&reg;;",
"     </li>",
"     <li>",
"      Apo-Verap&reg; SR;",
"     </li>",
"     <li>",
"      Covera-HS&reg;;",
"     </li>",
"     <li>",
"      Covera&reg;;",
"     </li>",
"     <li>",
"      Dom-Verapamil SR;",
"     </li>",
"     <li>",
"      Isoptin&reg; SR;",
"     </li>",
"     <li>",
"      Mylan-Verapamil;",
"     </li>",
"     <li>",
"      Mylan-Verapamil SR;",
"     </li>",
"     <li>",
"      Novo-Veramil;",
"     </li>",
"     <li>",
"      Novo-Veramil SR;",
"     </li>",
"     <li>",
"      Nu-Verap;",
"     </li>",
"     <li>",
"      Nu-Verap SR;",
"     </li>",
"     <li>",
"      PHL-Verapamil SR;",
"     </li>",
"     <li>",
"      PMS-Verapamil SR;",
"     </li>",
"     <li>",
"      PRO-Verapamil SR;",
"     </li>",
"     <li>",
"      Riva-Verapamil SR;",
"     </li>",
"     <li>",
"      Verapamil Hydrochloride Injection, USP;",
"     </li>",
"     <li>",
"      Verapamil SR;",
"     </li>",
"     <li>",
"      Verelan&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1056017\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antianginal Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiarrhythmic Agent, Class IV",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihypertensive Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Calcium Channel Blocker",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Calcium Channel Blocker, Nondihydropyridine",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1056010\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=see_link\">",
"      see \"Verapamil: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Although verapamil is effective in the treatment of SVT, it is not included in the PALS tachyarrhythmia algorithm due to its adverse effects (PALS, 2010).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants:",
"     <b>",
"      Should not be used in infants without expert consultation and is generally not recommended",
"     </b>",
"     ; administer with continuous ECG monitoring, have I.V. calcium available at bedside: 0.1-0.2 mg/kg/dose (usual: 0.75-2 mg/dose) may repeat dose in 30 minutes if adequate response not achieved;",
"     <b>",
"      Note:",
"     </b>",
"     Optimal interval for subsequent doses is unknown and must be individualized for each specific patient.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 1-15 years: 0.1-0.3 mg/kg/dose; maximum dose: 5 mg/dose; may repeat dose in 30 minutes if adequate response not achieved; maximum for second dose: 10 mg/dose;",
"     <b>",
"      Note:",
"     </b>",
"     Optimal interval for subsequent doses is unknown and must be individualized for each specific patient.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Dose not well established:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 4-8 mg/kg/day in 3 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     1-5 years: 40-80 mg every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;5 years: 80 mg every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     A mean daily dose of ~5 mg/kg/day (range: 2.3-8.1 mg/kg/day) was used in 22 children 15 days to 17 years of age receiving chronic oral therapy for SVT (n=20) or hypertrophic cardiomyopathy (n=2) (Piovan, 1995).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V. (ACLS 2010 guidelines): PSVT (narrow complex, unresponsive to vagal maneuvers and adenosine, in patients with preserved cardiac function): Initial: 2.5-5 mg; if no response in 15-30 minutes and no adverse effects seen, give 5-10 mg every 15-30 minutes to a maximum total dose of 20-30 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Manufacturer&rsquo;s recommendations: 5-10 mg (0.075-0.15 mg/kg); may repeat 10 mg (0.15 mg/kg) 30 minutes after the initial dose if needed and if patient tolerated initial dose;",
"     <b>",
"      Note:",
"     </b>",
"     Optimal interval for subsequent doses is unknown and must be individualized for each specific patient.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Angina: Oral:",
"     <b>",
"      Note:",
"     </b>",
"     When switching from immediate release to extended/sustained release formulations, the total daily dose remains the same unless formulation strength does not allow for equal conversion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Immediate release: Initial: 80-120 mg 3 times/day (small stature: 40 mg 3 times/day); usual dose range (Gibbons, 2003): 80-160 mg 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Extended release: Covera-HS&reg;: Initial: 180 mg once daily at bedtime; if inadequate response, may increase dose at weekly intervals to 240 mg once daily, then 360 mg once daily, then 480 mg once daily; maximum dose: 480 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Chronic atrial fibrillation (rate control), PSVT prophylaxis: Oral: Immediate release: 240-480 mg/day in 3-4 divided doses; usual dose range (European Heart Rhythm Association, 2006): 120-360 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hypertension: Oral:",
"     <b>",
"      Note:",
"     </b>",
"     When switching from immediate release to extended/sustained release formulations, the total daily dose remains the same unless formulation strength does not allow for equal conversion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Immediate release: 80 mg 3 times/day; usual dose range (JNC 7): 80-320 mg/day in 2 divided doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Sustained release: Usual dose range (JNC 7): 120-480 mg/day in 1-2 divided doses;",
"     <b>",
"      Note:",
"     </b>",
"     There is no evidence of additional benefit with doses &gt;360 mg/day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Calan&reg; SR, Isoptin&reg; SR: Initial: 180 mg once daily in the morning (small stature: 120 mg/day); if inadequate response, may increase dose at weekly intervals to 240 mg once daily, then 180 mg twice daily (or 240 mg in the morning followed by 120 mg in the evening); maximum dose: 240 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Verelan&reg;: Initial: 180 mg once daily in the morning (small stature: 120 mg/day); if inadequate response, may increase dose at weekly intervals to 240 mg once daily, then 360 mg once daily, then 480 mg once daily; maximum dose: 480 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Extended release: Usual dose range (JNC 7): 120-360 mg once daily (once daily dosing is recommended at bedtime)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Covera-HS&reg;: Initial: 180 mg once daily at bedtime; if inadequate response, may increase dose at weekly intervals to 240 mg once daily, then 360 mg once daily, then 480 mg once daily; maximum dose: 480 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Verelan&reg; PM: Initial: 200 mg once daily at bedtime (small stature: 100 mg once daily); if inadequate response, may increase dose at weekly intervals to 300 mg once daily, then 400 mg once daily; maximum dose: 400 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in renal impairment:",
"     </b>",
"     Children and Adults: Use with caution and closely monitor ECG for PR prolongation, blood pressure, and other signs of overdose; dosage reduction may be needed. The manufacturer of Verelan&reg; PM recommends an initial adult dose of 100 mg/day at bedtime.",
"     <b>",
"      Note:",
"     </b>",
"     A number of studies show no difference in verapamil (or norverapamil metabolite) disposition between chronic renal failure and control patients, suggesting that dosage adjustment is not required in renal impairment (Beyerlein, 1990; Hanyok, 1988; Mooy, 1985; Zachariah, 1991). However, a study in adults suggests reduced renal clearance of verapamil and its metabolite (norverapamil) with advanced renal failure (Storstein, 1984). Additionally, several clinical papers report adverse effects of verapamil in patients with chronic renal failure receiving recommended doses of verapamil (Pritza, 1991; V&aacute;quez, 1996). Thus, prudence dictates cautious use, close monitoring, and dosage adjustment if needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     Children and Adults: In patients with cirrhosis, reduce dose to 20% and 50% of normal dose for oral and intravenous administration, respectively; monitor blood pressure for hypotension and ECG for prolongation of PR interval (Somogyi, 1981). The manufacturer of Verelan PM&reg; recommends an initial adult dose of 100 mg/day at bedtime. The manufacturers of Calan&reg;, Calan&reg; SR, Covera-HS&reg;, Isoptin&reg; SR, and Verelan&reg; recommend giving 30% of the normal dose to patients with severe hepatic impairment.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F233831\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, sustained release, oral, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Calan&reg; SR: 120 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Calan&reg; SR: 180 mg, 240 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, extended release, oral, as hydrochloride: 120 mg, 180 mg, 240 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, extended release, controlled onset, oral, as hydrochloride: 100 mg, 200 mg, 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Verelan&reg; PM: 100 mg, 200 mg, 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, sustained release, oral, as hydrochloride: 120 mg, 180 mg, 240 mg, 360 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Verelan&reg;: 120 mg, 180 mg, 240 mg, 360 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride: 2.5 mg/mL (2 mL, 4 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as hydrochloride: 40 mg, 80 mg, 120 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Calan&reg;: 80 mg, 120 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, oral, as hydrochloride: 120 mg, 180 mg, 240 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, controlled onset, oral, as hydrochloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Covera-HS&reg;: 180 mg [DSC], 240 mg [DSC]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, sustained release, oral, as hydrochloride: 120 mg, 180 mg, 240 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Isoptin&reg; SR: 120 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Isoptin&reg; SR: 180 mg, 240 mg [DSC] [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F233816\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes caplet (sustained release) and tablet (extended release, controlled onset)",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1056021\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Do not administer with grapefruit juice. Nonsustained-release tablets can be administered with or without food. Swallow extended and sustained released preparations whole, do not break, chew, or crush. Administer Calan&reg; SR and Isoptin&reg; SR with food on a once daily or twice daily schedule; administer Covera-HS&reg; and Verelan&reg; PM once daily at bedtime. Administer Verelan&reg; (sustained release capsules) once daily in the morning; capsule may be opened and contents sprinkled on a spoonful of applesauce; swallow immediately, do not chew; do not store for future use; follow with water to ensure complete swallowing of capsule pellets; do not divide capsule",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: I.V.: Infuse I.V. dose over 2-3 minutes; infuse I.V. over 3-4 minutes if blood pressure is in the lower range of normal: Maximum concentration: 2.5 mg/mL",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F233918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in dextran 40 10% in NS, dextran 75 6% in NS, D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, NS.",
"     <b>",
"      Note:",
"     </b>",
"     Physically compatible in solutions of pH of 3-6, but may precipitate in solutions having a pH &gt;6.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Argatroban, bivalirudin, ciprofloxacin, clonidine, dexmedetomidine, dobutamine, dopamine, eptifibatide, famotidine, fenoldopam, hetastarch in lactate electrolyte injection (Hextend&reg;), hydralazine, inamrinone, linezolid, meperidine, milrinone, nesiritide, oxaliplatin, penicillin G potassium, piperacillin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Albumin, amphotericin B cholesteryl sulfate complex, ampicillin, nafcillin, oxacillin, pantoprazole, sodium bicarbonate.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Aminophylline, propofol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Dimenhydrinate, heparin, inamrinone, milrinone.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Pantoprazole.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1056013\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection: Store at controlled room temperature of 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); protect from light; use only clear solutions. Compatible in solutions of pH of 3-6, but may precipitate in solutions having a pH &ge;6",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calan&reg;: Store at 15&deg;C to 25&deg;C (59&deg;F to 77&deg;F); protect from light; dispense in tightly closed, light-resistant container.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calan&reg; SR: Store at 15&deg;C to 25&deg;C (59&deg;F to 77&deg;F); protect from light and moisture; dispense in tightly closed, light-resistant container.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Covera-HS&reg;: Store at controlled room temperature of 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); dispense in tightly closed, light-resistant container.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Isoptin&reg; SR: Store at 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); protect from light and moisture; dispense in tightly closed, light-resistant container.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Verelan&reg;: Store at controlled room temperature of 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); avoid excessive heat; dispense in tightly closed, light-resistant container.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Verelan&reg; PM: Store at 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (59&deg;F to 86&deg;F); protect from moisture; dispense in tightly closed, light-resistant container.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1056020\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Treatment of hypertension (all oral products) (FDA approved in adults); angina pectoris (vasospastic, chronic stable, unstable) (Calan&reg;, Covera-HS&reg;) (FDA approved in adults); supraventricular tachyarrhythmia [PSVT (prophylaxis), atrial fibrillation/flutter (rate control)] (Calan&reg;) (FDA approved in adults)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V.: Supraventricular tachyarrhythmia [PSVT; atrial fibrillation/flutter (rate control)] (FDA approved in all ages)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F233920\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Calan&reg; may be confused with Colace&reg;, diltiazem",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Covera-HS&reg; may be confused with Provera&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Isoptin&reg; may be confused with Isopto&reg; Tears",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Verelan&reg; may be confused with Voltaren&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication (I.V. formulation) among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Significant differences exist between oral and I.V. dosing. Use caution when converting from one route of administration to another.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Dilacor [Brazil]  may be confused with Dilacor XR brand name for diltiazem [U.S.]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F233917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular:  AV block, bradycardia, CHF/pulmonary edema, flushing, hypotension, peripheral edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, fatigue, headache, lethargy, pain, sleep disturbance",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Constipation, diarrhea, dyspnea, gingival hyperplasia, nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Liver enzymes increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Myalgia, paresthesia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but  important or life-threatening:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Oral:",
"     </b>",
"     Abdominal discomfort, alopecia, angina, arthralgia, atrioventricular dissociation, blurred vision, bruising, cerebrovascular accident, chest pain, claudication, confusion, diaphoresis, ECG abnormal, equilibrium disorders, erythema multiforme, exanthema, extrapyramidal symptoms, galactorrhea/hyperprolactinemia, gastrointestinal distress, gynecomastia, hyperkeratosis, impotence, insomnia, macules, MI, muscle cramps, palpitation, psychosis, purpura (vasculitis), shakiness, somnolence, spotty menstruation, Stevens-Johnson syndrome, syncope, tinnitus, urination increased, urticaria, weakness, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      I.V.:",
"     </b>",
"     Bronchi/laryngeal spasm, depression, diaphoresis, itching, muscle fatigue, respiratory failure, rotary nystagmus, seizure, sleepiness, urticaria, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Asystole, eosinophilia, EPS, exfoliative dermatitis, GI obstruction, hair color change, paralytic ileus, Parkinsonian syndrome, pulseless electrical activity, shock, ventricular fibrillation",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1056026\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to verapamil or any component; severe left ventricular dysfunction;  hypotension or cardiogenic shock; sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker); second- or third-degree AV block (except in patients with a functioning artificial ventricular pacemaker); atrial flutter or fibrillation associated with an accessory bypass tract [Wolff-Parkinson-White (WPW) syndrome, Lown-Ganong-Levine syndrome]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V.: Additional contraindications include concurrent use of I.V. beta-blocking agents; ventricular tachycardia; severe congestive heart failure (unless secondary to supraventricular tachycardia that is treatable with verapamil)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1056009\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hypertrophic cardiomyopathy (especially obstructive) or concomitant therapy with beta-blockers or digoxin (verapamil may significantly increase digoxin serum concentrations; adjust digoxin dose). Use caution in patients with hepatic or renal impairment (verapamil dosage reduction may be needed; monitor for signs of overdosage, including hypotension or PR prolongation on ECG). Verapamil may decrease neuromuscular transmission in patients with Duchenne's muscular dystrophy and may worsen myasthenia gravis (use with caution in these patients; verapamil dosage reduction may be needed). Use Covera-HS&reg; with caution in patients with severe GI narrowing (table is nondeformable) and in patients with extremely short GI transit time (&lt;7 hours) (dosage adjustment may be required; pharmacokinetic data are not available ).",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1056008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid I.V. use in neonates and young infants due to severe apnea, bradycardia, hypotensive reactions, cardiac arrest. I.V. use is discouraged in children due to hypotension and myocardial depression. Although effective in terminating SVT in older children, verapamil is not the drug of choice (due to adverse effects) and is not included in the current PALS tachyarrhythmia algorithm. Monitor ECG and blood pressure closely in patients receiving I.V. therapy; have I.V. calcium chloride available at bedside to treat hypotension. I.V. administration, hypertrophic cardiomyopathy, sick sinus syndrome, moderate to severe CHF, concomitant therapy with beta-blockers or digoxin can all increase the incidence of adverse effects.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Use caution when using verapamil together with agents with SA/AV nodal-blocking properties. Administration of I.V. verapamil and an I.V. beta-blocker within a few hours of each other may result in asystole and should be avoided; simultaneous administration is contraindicated. Use with other agents known to reduce SA node function and/or AV nodal conduction (eg, digoxin) or reduce sympathetic outflow (eg, clonidine) may increase the risk of serious bradycardia.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F233905\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2B6 (minor), CYP2C9 (minor), CYP2E1 (minor), CYP3A4 (major), P-glycoprotein;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2C9 (weak), CYP2D6 (weak), CYP3A4 (moderate), P-glycoprotein",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F233825\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): Verapamil may increase the serum concentration of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aliskiren: Verapamil may increase the serum concentration of Aliskiren.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: May enhance the hypotensive effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amifostine: Antihypertensives may enhance the hypotensive effect of Amifostine.  Management: When amifostine is used at chemotherapy doses, antihypertensive medications should be withheld for 24 hours prior to amifostine administration. If antihypertensive therapy can not be withheld, amifostine should not be administered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amiodarone: Calcium Channel Blockers (Nondihydropyridine) may enhance the bradycardic effect of Amiodarone. Sinus arrest has been reported.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anilidopiperidine Opioids: May enhance the bradycardic effect of Calcium Channel Blockers (Nondihydropyridine). Anilidopiperidine Opioids may enhance the hypotensive effect of Calcium Channel Blockers (Nondihydropyridine).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antifungal Agents (Azole Derivatives, Systemic): May enhance the adverse/toxic effect of Calcium Channel Blockers. Specifically, itraconazole may enhance the negative inotropic effects of verapamil or diltiazem. Antifungal Agents (Azole Derivatives, Systemic) may decrease the metabolism of Calcium Channel Blockers. Management: Concurrent use of felodipine or nisoldipine with itraconazole is specifically contraindicated.  Frequent monitoring is warranted with any such combination; calcium channel blocker dose reductions may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensives: May enhance the hypotensive effect of other Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtorvaSTATin: May increase the serum concentration of Verapamil. Verapamil may increase the serum concentration of AtorvaSTATin. Management: Consider using lower atorvastatin doses when used together with verapamil.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atosiban: Calcium Channel Blockers may enhance the adverse/toxic effect of Atosiban. Specifically, there may be an increased risk for pulmonary edema and/or dyspnea.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Avanafil: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Avanafil.  Management: The maximum avanafil adult dose is 50 mg per 24-hour period when used together with a moderate CYP3A4 inhibitor.  Patients receiving such a combination should also be monitored more closely for evidence of adverse effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May increase the metabolism of Calcium Channel Blockers. Management: Monitor for decreased therapeutic effects of calcium channel blockers with concomitant barbiturate therapy. Calcium channel blocker dose adjustments may be necessary. Nimodipine Canadian labeling contraindicates concomitant use with phenobarbital.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepines (metabolized by oxidation): Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Calcium Channel Blockers (Nondihydropyridine) may enhance the hypotensive effect of Beta-Blockers. Bradycardia and signs of heart failure have also been reported. Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Budesonide (Systemic, Oral Inhalation): CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Budesonide (Systemic, Oral Inhalation).  Management: Consider reducing the oral budesonide dose when used together with a CYP3A4 inhibitor.  This interaction is likely less severe with orally inhaled budesonide.  Monitor patients closely for signs/symptoms of corticosteroid excess.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BusPIRone: Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of BusPIRone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Channel Blockers (Dihydropyridine): May enhance the hypotensive effect of Calcium Channel Blockers (Nondihydropyridine). Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Calcium Channel Blockers (Dihydropyridine).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts: May diminish the therapeutic effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May decrease the serum concentration of Calcium Channel Blockers (Nondihydropyridine). Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of CarBAMazepine. Management: Consider empiric reductions in carbamazepine dose with initiation of nondihydropyridine calcium channel blockers. Monitor for increased toxic effects of carbamazepine and reduced therapeutic effects of the calcium channel blocker.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Calcium Channel Blockers (Nondihydropyridine) may enhance the AV-blocking effect of Cardiac Glycosides. Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Cardiac Glycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May increase the serum concentration of Calcium Channel Blockers. Management: Consider alternatives to cimetidine. If no suitable alternative exists, monitor for increased effects of calcium channel blockers following cimetidine initiation/dose increase, and decreased effects following cimetidine discontinuation/dose decrease.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloNIDine: May enhance the AV-blocking effect of Calcium Channel Blockers (Nondihydropyridine). Sinus node dysfunction may also be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Clopidogrel: Calcium Channel Blockers may diminish the therapeutic effect of Clopidogrel.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Colchicine.  Management: Reduce colchicine dose as directed when using with a moderate CYP3A4 inhibitor, and increase monitoring for colchicine-related toxicity.  Use extra caution in patients with impaired renal and/or hepatic function.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Colchicine. Colchicine distribution into certain tissues (e.g., brain) may also be increased.  Management: Colchicine is contraindicated in patients with impaired renal or hepatic function who are also receiving a p-glycoprotein inhibitor.  In those with normal renal and hepatic function, reduce colchicine dose as directed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Conivaptan: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of Corticosteroids (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): May decrease the metabolism of Calcium Channel Blockers (Nondihydropyridine). Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of CycloSPORINE (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Substrates: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Verapamil may increase serum concentrations of the active metabolite(s) of Dabigatran Etexilate.  Management: Consider giving dabigatran 2 hrs before oral verapamil; other dose reductions may be needed. Specific recommendations vary by US vs Canadian labeling, renal function, and indication for dabigatran.  Refer to full monograph or dabigatran labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dantrolene: May enhance the hyperkalemic effect of Calcium Channel Blockers (Nondihydropyridine). Dantrolene may enhance the negative inotropic effect of Calcium Channel Blockers (Nondihydropyridine). Management: This interaction has only been described with intravenous dantrolene administration.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diazoxide: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disopyramide: Verapamil may enhance the adverse/toxic effect of Disopyramide. Of particular concern is the potential for profound depression of myocardial contractility.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dofetilide: Verapamil may increase the serum concentration of Dofetilide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dronedarone: Calcium Channel Blockers (Nondihydropyridine) may enhance the AV-blocking effect of Dronedarone. Other electrophysiologic effects of Dronedarone may also be increased. Dronedarone may increase the serum concentration of Calcium Channel Blockers (Nondihydropyridine). Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Dronedarone.  Management: Use lower starting doses of the nondihydropyridine calcium channel blockers (i.e., verapamil, diltiazem), and only consider increasing calcium channel blocker dose after obtaining ECG-based evidence that the combination is being well-tolerated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eletriptan: Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of Eletriptan.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of Eplerenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Everolimus.  Management: Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma.  See prescribing information for specific dose adjustment and monitoring recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Everolimus.  Management: Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma.  See prescribing information for specific dose adjustment and monitoring recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fexofenadine: Verapamil may increase the bioavailability of Fexofenadine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: Verapamil may enhance the bradycardic effect of Fingolimod.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Flecainide: Verapamil may enhance the adverse/toxic effect of Flecainide. In particular, this combination may significantly impair myocardial contractility and AV nodal conduction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fluconazole: May decrease the metabolism of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: Calcium Channel Blockers may increase the serum concentration of Fosphenytoin.  Management: Monitor for phenytoin toxicity with concomitant use of a calcium channel blocker (CCB) or decreased phenytoin effects with CCB discontinuation. Monitor for decreased CCB therapeutic effects. Nimodipine Canadian labeling contraindicates use with phenytoin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Grapefruit Juice: May increase the serum concentration of Verapamil.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Halofantrine: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Halofantrine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypertensive Properties): May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypotensive Properties): May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ifosfamide: CYP3A4 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Ifosfamide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivabradine: Calcium Channel Blockers (Nondihydropyridine) may enhance the bradycardic effect of Ivabradine. Ivabradine may enhance the QTc-prolonging effect of Calcium Channel Blockers (Nondihydropyridine). Specifically, the QTc prolonging effects of bepridil may be enhanced. Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Ivabradine. Specifically, verapamil or diltiazem may increase serum ivabradine concentrations.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Ivacaftor.  Management: Decrease ivacaftor dose to 150 mg daily in patients also receiving moderate CYP3A4 inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Calcium Channel Blockers (Nondihydropyridine) may enhance the neurotoxic effect of Lithium. Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Lithium. Decreased or unaltered lithium concentrations have also been reported with this combination.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Lomitapide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lovastatin: Verapamil may increase the serum concentration of Lovastatin.  Management: Initiate lovastatin at a maximum adult dose of 10 mg/day, and do not exceed 20 mg/day, in patients receiving verapamil. Monitor closely for signs of HMG-CoA reductase inhibitor toxicity (e.g., myositis, rhabdomyolysis).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lurasidone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Lurasidone.  Management: U.S. labeling: start at 20 mg/day and limit to max of 80 mg/day with moderate CYP3A4 inhibitor.  Canadian labeling: limit to max of 40 mg/day with moderate CYP3A4 inhibitor; avoid concomitant use of grapefruit products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May decrease the metabolism of Calcium Channel Blockers. Management: Consider using a noninteracting macrolide. Monitor for increased therapeutic effects of calcium channel blockers if an interacting macrolide antibiotic is initiated, or decreased effects if a macrolide is discontinued.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Azithromycin (Systemic); Fidaxomicin; Spiramycin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Salts: Calcium Channel Blockers may enhance the adverse/toxic effect of Magnesium Salts. Magnesium Salts may enhance the hypotensive effect of Calcium Channel Blockers.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypotensive effect of Antihypertensives. MAO Inhibitors may enhance the orthostatic hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Midodrine: Calcium Channel Blockers (Nondihydropyridine) may enhance the bradycardic effect of Midodrine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May increase the serum concentration of CYP3A4 Substrates. Management: Minimize doses of CYP3A4 substrates, and monitor for increased concentrations/toxicity, during and 2 weeks following treatment with mifepristone. Avoid cyclosporine, dihydroergotamine, ergotamine, fentanyl, pimozide, quinidine, sirolimus, and tacrolimus.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nafcillin: May increase the metabolism of Calcium Channel Blockers.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents (Nondepolarizing): Calcium Channel Blockers may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents (Nondepolarizing).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nitroprusside: Calcium Channel Blockers may enhance the hypotensive effect of Nitroprusside.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inhibitors: May increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Substrates: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: Calcium Channel Blockers may increase the serum concentration of Phenytoin.  Management: Monitor for phenytoin toxicity with concomitant use of a calcium channel blocker (CCB) or decreased phenytoin effects with CCB discontinuation. Monitor for decreased CCB therapeutic effects. Nimodipine Canadian labeling contraindicates use with phenytoin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phosphodiesterase 5 Inhibitors: May enhance the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of Pimecrolimus.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pomalidomide: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Pomalidomide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Propafenone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Propafenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protease Inhibitors: May decrease the metabolism of Calcium Channel Blockers (Nondihydropyridine). Increased serum concentrations of the calcium channel blocker may increase risk of AV nodal blockade. Management: Avoid concurrent use when possible. If this combination is used, monitor for evidence of toxicity. The manufacturer of atazanavir recommends a 50% dose reduction for diltiazem be considered. Saquinavir or tipranavir use with bepridil is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prucalopride: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Prucalopride.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: May enhance the hypotensive effect of Verapamil. Verapamil may increase the serum concentration of QuiNIDine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ranolazine: Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Ranolazine.  Management: Limit ranolazine dose to a maximum of 500 mg twice daily when used with diltiazem or verapamil.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Red Yeast Rice: Calcium Channel Blockers (Nondihydropyridine) may increase the serum concentration of Red Yeast Rice. Specifically, concentrations of lovastatin (and possibly other related compounds) may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May increase the metabolism of Calcium Channel Blockers. This primarily affects oral forms of calcium channel blockers. Management: The labeling for some U.S. and Canadian calcium channel blockers contraindicate use with rifampin however recommendations vary. Consult appropriate labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RisperiDONE: Verapamil may increase the serum concentration of RisperiDONE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RiTUXimab: Antihypertensives may enhance the hypotensive effect of RiTUXimab.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Verapamil may increase the serum concentration of Rivaroxaban.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: Calcium Channel Blockers (Nondihydropyridine) may enhance the anticoagulant effect of Salicylates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salmeterol: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Salmeterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Simvastatin: Verapamil may increase the serum concentration of Simvastatin.  Management: Avoid concurrent use of verapamil with simvastatin when possible.   If used together, limit adult maximum simvastatin dose to 10 mg/day, and avoid Simcor (simvastatin/niacin) because fixed simvastatin doses in the product exceed this maximum.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Systemic): Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of Tacrolimus (Systemic).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): Calcium Channel Blockers (Nondihydropyridine) may decrease the metabolism of Tacrolimus (Topical).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telithromycin: May enhance the hypotensive effect of Verapamil.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tolvaptan: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Tolvaptan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topotecan: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Topotecan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vilazodone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Vilazodone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     VinCRIStine (Liposomal): P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of VinCRIStine (Liposomal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Yohimbine: May diminish the antihypertensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zuclopenthixol: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Zuclopenthixol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1056028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Grapefruit juice may increase verapamil serum concentrations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Calan&reg; SR and Isoptin&reg; SR: Food may decrease bioavailability but produces a narrow peak to trough ratio.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Covera-HS&reg;: A high-fat meal does not affect absorption.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Verelan&reg;: Food does not affect rate or extent of absorption; rate and extent of absorption are bioequivalent between administration of intact capsule and when contents of capsule are administered by sprinkling onto one tablespoonful of applesauce.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Verelan&reg; PM: A high-fat meal slightly affects the rate but not the extent of absorption.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F233827\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F233843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In some animal reproduction studies verapamil has been shown to cause fetal harm; adverse maternal effects were also observed. Verapamil crosses the placenta. Although verapamil is not considered a major human teratogen, use during pregnancy may cause adverse fetal effects (bradycardia, heart block, hypotension).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1056016\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     ECG, blood pressure, heart rate; hepatic enzymes with long-term use",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1056007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits calcium ions from entering the &ldquo;slow channels&rdquo; or select voltage-sensitive areas of vascular smooth muscle and myocardium during depolarization; produces a relaxation of coronary vascular smooth muscle and coronary vasodilation; increases myocardial oxygen delivery in patients with vasospastic angina",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1056024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral (nonsustained tablets): 2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 1-5 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 10-20 minutes",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1056025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Well-absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 3.89 L/kg (Storstein, 1984)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neonates: ~60%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: ~90%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensive first-pass effect, metabolized in the liver to several inactive dealkylated metabolites; major metabolite is norverapamil which possesses weak hemodynamic effects (20% that of verapamil)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Oral: 20% to 30%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants: 4.4-6.9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults (single dose): 2-8 hours, increased up to 12 hours with multiple dosing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: Severe hepatic impairment: 14-16 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: 70% of dose excreted in urine as metabolites (3% to 4% as unchanged drug), and 16% in feces",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: Not removed by hemodialysis",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1056015\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?5/53/5974?source=see_link\">",
"      see \"Verapamil: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Avoid alcohol and grapefruit juice; limit caffeine; insoluble shell of extended release tablet (eg, Covera-HS&reg;) may appear in the stool (this is normal)",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F233838\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A 50 mg/mL oral suspension may be made with immediate release tablets and either a 1:1 mixture of Ora-Sweet&reg; and Ora-Plus&reg; or a 1:1 mixture of Ora-Sweet&reg; SF and Ora-Plus&reg; or cherry syrup. When using cherry syrup, dilute cherry syrup concentrate 1:4 with simple syrup, NF. Crush seventy-five verapamil hydrochloride 80 mg tablets in a mortar and reduce to a fine powder. Add small portions of chosen vehicle (40 mL total) and mix to a uniform paste; mix while adding the vehicle in incremental proportions to",
"     <b>",
"      almost",
"     </b>",
"     120 mL; transfer to a calibrated bottle, rinse mortar with vehicle, and add quantity of vehicle sufficient to make 120 mL. Label \"shake well\", \"refrigerate\", and \"protect from light\". Stable for 60 days refrigerated (preferred) or at room temperature (Allen, 1996).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     A 50 mg/mL oral suspension may be made with immediate release tablets, a 1:1 preparation of methylcellulose 1% and simple syrup, and purified water. Crush twenty 80 mg verapamil tablets in a mortar and reduce to a fine powder. Add 3 mL purified water USP and mix to a uniform paste; mix while adding the vehicle incremental proportions to",
"     <b>",
"      almost",
"     </b>",
"     32 mL; transfer to a calibrated bottle, rinse mortar with vehicle, and add quantity of vehicle sufficient to make 32 mL. Label \"shake well\" and  \"refrigerate\". Stable for 91 days refrigerated (preferred) or at room temperature (Nahata, 1997).",
"    </p>",
"    <div class=\"reference\">",
"     Allen LV Jr and Erickson MA 3rd, \"Stability of Labetalol Hydrochloride, Metoprolol Tartrate, Verapamil Hydrochloride, and Spironolactone With Hydrochlorothiazide in Extemporaneously Compounded Oral Liquids,\"",
"     <i>",
"      Am J Health Syst Pharm",
"     </i>",
"     , 1996, 53(19):304-9.",
"     <span class=\"pubmed-id\">",
"      8893069",
"     </span>",
"    </div>",
"    <div class=\"reference\">",
"     Nahata MC, \"Stability of Verapamil in an Extemporaneous Liquid Dosage Form,\"",
"     <i>",
"      J Appl Ther Res",
"     </i>",
"     , 1997,1(3):271-3.",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Beyerlein C, Csaszar G, Hollmann M, et al, \"Verapamil in Antihypertensive Treatment of Patients on Renal Replacement Therapy - Clinical Implications and Pharmacokinetics,\"",
"      <i>",
"       Eur J Clin Pharmacol",
"      </i>",
"      , 1990, 39 Suppl 1:S35-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/2261942/pubmed\" id=\"2261942\" target=\"_blank\">",
"        2261942",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chobanian AV, Bakris GL, Black HR, et al, &ldquo;The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2003, 289(19):2560-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/12748199 /pubmed\" id=\"12748199 \" target=\"_blank\">",
"        12748199",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      European Heart Rhythm Association; Heart Rhythm Society, Fuster V, et al, \"ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation - Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation),\"",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2006, 48(4):854-906.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/16904574/pubmed\" id=\"16904574\" target=\"_blank\">",
"        16904574",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Field JM, Hazinski MF, Sayre MR, et al, \"Part 1: Executive Summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(18 Suppl 3):S640-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/20956217 /pubmed\" id=\"20956217 \" target=\"_blank\">",
"        20956217",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gibbons RJ, Abrams J, Chatterjee K, et al, \"ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina - Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina),\"",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2003, 41(1):159-68.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/12570960/pubmed\" id=\"12570960\" target=\"_blank\">",
"        12570960",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hanyok JJ, Chow MS, Kluger J, et al, \"An Evaluation of the Pharmacokinetics, Pharmacodynamics, and Dialyzability of Verapamil in Chronic Hemodialysis Patients,\"",
"      <i>",
"       J Clin Pharmacol",
"      </i>",
"      , 1988, 28(9):831-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/3230150/pubmed\" id=\"3230150\" target=\"_blank\">",
"        3230150",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kleinman ME, Chameides L, Schexnayder SM, et al, \"Part 14: Pediatric Advanced Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(18 Suppl 3):S876-908.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/20956230/pubmed\" id=\"20956230\" target=\"_blank\">",
"        20956230",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mooy J, Schols M, v Baak M, et al, \"Pharmacokinetics of Verapamil in Patients With Renal Failure,\"",
"      <i>",
"       Eur J Clin Pharmacol",
"      </i>",
"      , 1985, 28(4):405-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/4029246/pubmed\" id=\"4029246\" target=\"_blank\">",
"        4029246",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Neumar RW, Otto CW, Link MS, et al, \"Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(18 Suppl 3):729-67.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/20956224/pubmed\" id=\"20956224\" target=\"_blank\">",
"        20956224",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Piovan D, Padrini R, Svalato Moreolo G, et al, &ldquo;Verapamil and Norverapamil Plasma Levels in Infants and Children During Chronic Oral Treatment,&rdquo;",
"      <i>",
"       Ther Drug Monit",
"      </i>",
"      , 1995, 17(1):60-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/ 7725379 /pubmed\" id=\" 7725379 \" target=\"_blank\">",
"        7725379",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pritza DR, Bierman MH, and Hammeke MD, \"Acute Toxic Effects of Sustained-Release Verapamil in Chronic Renal Failure,\"",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 1991, 151(10):2081-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/1843183/pubmed\" id=\"1843183\" target=\"_blank\">",
"        1843183",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sapire DW, O'Riordan AC, and Black IF, &ldquo;Safety and Efficacy of Short- and Long-Term Verapamil Therapy in Children With Tachycardia,&rdquo;",
"      <i>",
"       Am J Cardiol",
"      </i>",
"      , 1981, 48(6):1091-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/6795914 /pubmed\" id=\"6795914 \" target=\"_blank\">",
"        6795914",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shakibi JG, &ldquo;Arrhythmias in Infants and Children,&rdquo;",
"      <i>",
"       Pediatrician",
"      </i>",
"      , 1981, 10(1-3):117-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/7243302/pubmed\" id=\"7243302\" target=\"_blank\">",
"        7243302",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Somogyi A, Albrecht M, Kliems G, et al, \"Pharmacokinetics, Bioavailability and ECG Response of Verapamil in Patients With Liver Cirrhosis,\"",
"      <i>",
"       Br J Clin Pharmacol",
"      </i>",
"      , 1981, 12(1):51-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/7248141/pubmed\" id=\"7248141\" target=\"_blank\">",
"        7248141",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Storstein L, Larsen A, Midtb&oslash; K, et al, \"Pharmacokinetics of Calcium Blockers in Patients With Renal Insufficiency and in Geriatric Patients,\"",
"      <i>",
"       Acta Med Scand Suppl",
"      </i>",
"      , 1984, 681:25-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/6587753/pubmed\" id=\"6587753\" target=\"_blank\">",
"        6587753",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      V&aacute;quez C, Huelmos A, Alegr&iacute;a E, et al, \"Verapamil Deleterious Effects in Chronic Renal Failure,\"",
"      <i>",
"       Nephron",
"      </i>",
"      , 1996, 72(3):461-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/8852497/pubmed\" id=\"8852497\" target=\"_blank\">",
"        8852497",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zachariah PK, Moyer TP, Theobald HM, et al, \"The Pharmacokinetics of Racemic Verapamil in Patients With Impaired Renal Function,\"",
"      <i>",
"       J Clin Pharmacol",
"      </i>",
"      , 1991, 31(1):45-53.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/3/33849/abstract-text/2045528/pubmed\" id=\"2045528\" target=\"_blank\">",
"        2045528",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12879 Version 46.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-83.177.194.223-77399545CD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33849=[""].join("\n");
var outline_f33_3_33849=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233861\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233862\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056017\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056010\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233831\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233816\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056021\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233918\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056013\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056020\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233920\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233917\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056026\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056009\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056008\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233905\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233825\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056028\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233827\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233843\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056016\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056007\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056024\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056025\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1056015\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233838\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12879\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12879|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?9/18/9514?source=related_link\">",
"      Verapamil: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?5/53/5974?source=related_link\">",
"      Verapamil: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_3_33850="Cardiac examination for VSD";
var content_f33_3_33850=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F56343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F56343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 642px\">",
"   <div class=\"ttl\">",
"    Cardiac examination for VSD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 622px; height: 560px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Graphic illustration of the cardiac examination in ventricular septal defect (VSD).",
"    <br/>",
"    (A) Holosystolic murmur of VSD.",
"    <br/>",
"    (B) Shortened systolic murmur of muscular (VSD).",
"    <br/>",
"    (C) Typical murmur of VSD with mild pulmonary stenosis (PS) showing the delayed pulmonary closure sound (P",
"    <sub>",
"     2",
"    </sub>",
"    ).",
"    <br/>",
"    (D) Systolic ejection murmur of severe pulmonary stenosis with delayed and reduced P",
"    <sub>",
"     2",
"    </sub>",
"    .",
"    <br/>",
"    (E) Eisenmenger complex with absence of the holosystolic murmur of VSD (see text), a loud P",
"    <sub>",
"     2",
"    </sub>",
"    secondary to pulmonary hypertension, and pulmonary regurgitation (PR) diastolic murmur.",
"    <br/>",
"    (F) VSD murmur followed by diastolic murmur of aortic regurgitation (AR).",
"    <div class=\"footnotes\">",
"     S",
"     <sub>",
"      1",
"     </sub>",
"     : first heart sound; A",
"     <sub>",
"      2",
"     </sub>",
"     : aortic closure sound.",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission Ammash N. Ventricular Septal Defects. In: Adult Congenital Heart Disease, Warnes, CA (Ed). &copy; 2009 American Heart Association, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33850=[""].join("\n");
var outline_f33_3_33850=null;
var title_f33_3_33851="Components fibrinolytic system";
var content_f33_3_33851=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F70156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F70156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Components of the plasma fibrinolytic system",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Molecular weight (d)",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Activity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Plasminogen",
"       </td>",
"       <td>",
"        88,000 (single chain)",
"       </td>",
"       <td>",
"        Proenzyme form of fibrinolytic enzyme",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Plasmin",
"       </td>",
"       <td>",
"        88,000 (two chain)",
"       </td>",
"       <td>",
"        Active fibrinolytic enzyme",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        TPA",
"       </td>",
"       <td>",
"        70,000 (one/two chain)",
"       </td>",
"       <td>",
"        Enzyme present in tissues that coverts plasminogen to plasmin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        UPA",
"       </td>",
"       <td>",
"        54,000 (two chain)",
"        <br/>",
"       </td>",
"       <td>",
"        Plasminogen activator (different from tPA)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        &alpha;2PI",
"       </td>",
"       <td>",
"        70,000 (single chain)",
"       </td>",
"       <td>",
"        Specific fast-acting inhibitor in plasma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        PAI-1",
"       </td>",
"       <td>",
"        40,000 (single chain)",
"       </td>",
"       <td>",
"        Fast-acting inhibitor of tPA (and UPA) secreted by endothelial cells)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     d: Daltons; TPA: tissue plasminogen activator; UPA: urokinase-like plasminogen activator; &alpha;2PI: alpha-2 plasmin inhibitor; PAI-1: plasminogen activator inhibitor-1.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33851=[""].join("\n");
var outline_f33_3_33851=null;
var title_f33_3_33852="ECG and action potential";
var content_f33_3_33852=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F78354&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F78354&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ventricular action potential and QRS-T cycle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 262px; height: 270px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The QRS-T cycle on the electrocardiogram corresponds to different phases of the ventricular action potential.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33852=[""].join("\n");
var outline_f33_3_33852=null;
var title_f33_3_33853="Contents: Emergency med calculators";
var content_f33_3_33853=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?10/42/10926\">",
"       Adult and Pediatric Emergency Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Emergency med calculators",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Emergency med calculators",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Medical Equations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/34/34337\">",
"           Calculator: Adult burn injury fluid resuscitation (Parkland crystalloid estimate)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/29/11730\">",
"           Calculator: Blood ethanol concentration estimation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/26/18849\">",
"           Calculator: Endotracheal tube size for children (Age 1 to 8 years)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/41/2706\">",
"           Calculator: Ideal body weight (method of Devine) and dosing weight for adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/26/29089\">",
"           Calculator: Lean body weight (adult female)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/21/29009\">",
"           Calculator: Lean body weight (adult male)",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-3CE4F53A01-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f33_3_33853=[""].join("\n");
var outline_f33_3_33853=null;
var title_f33_3_33854="Anterior uveitis in a patient with IBD";
var content_f33_3_33854=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F75384&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F75384&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anterior uveitis in a patient with inflammatory bowel disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 233px; height: 177px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Anterior uveitis in a patient with inflammatory bowel disease is characterized by injection of the conjunctiva and opacity in the anterior chamber.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of the American Gastroenterological Association&copy;. This slide cannot be downloaded but may be purchased as part of a set from the AGA through Milner-Fenwick, Inc at 1-800-432-8433.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33854=[""].join("\n");
var outline_f33_3_33854=null;
var title_f33_3_33855="Pathologic LVH vs Physiologic LVH";
var content_f33_3_33855=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F87658&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F87658&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pathologic LVH vs Physiologic LVH",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 336px; height: 506px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Comparison of features which can be useful in distinguishing Pathologic LVH from Physiologic LVH.",
"    <div class=\"footnotes\">",
"     LA: left atrium; LV: left ventricle; LVH: left ventricular hypertrophy; ECG: electrocardiogram; HCM: hypertrophic cardiomyopathy.",
"    </div>",
"    <div class=\"reference\">",
"     Additional updated information from:",
"     <br>",
"      <ol>",
"       <li>",
"        Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet 2012.",
"       </li>",
"       <li>",
"        Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation 2006; 114:1633.",
"       </li>",
"      </ol>",
"      Reproduced with permission from: Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995; 91:1596.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_3_33855=[""].join("\n");
var outline_f33_3_33855=null;
